{
  "20150820_Haura-Pilot-TMT1-bRPLC11-1.raw": {
    "Source Name": [
      "20150820_Haura-Pilot-TMT1-bRPLC11-1"
    ],
    "Assay Name": [
      "20150820_Haura-Pilot-TMT1-bRPLC11-1.raw"
    ],
    "Raw Data File": [
      "20150820_Haura-Pilot-TMT1-bRPLC11-1.raw"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin digestion was carried out overnight at 37 \u00b0C"
    ],
    "Characteristics[ReductionReagent]": [
      "reduced with 4.5 mM DTT at 60 \u00b0C for 20 minutes"
    ],
    "Characteristics[AlkylationReagent]": [
      "alkylation with 11 mM iodoacetamide at room temperature for 15 minutes in the dark"
    ],
    "Characteristics[Label]": [
      "TMT 6-plex"
    ],
    "Characteristics[MaterialType]": [
      "Tissue samples were homogenized with a BioPulverizer (Biospec) and resuspended in lysis buffer containing 20 mM HEPES, pH 8.0, 9 M urea, 1 mM sodium orthovanadate, 2.5 mM sodium pyrophosphate, and 1 mM \u03b2-glycerophosphate."
    ],
    "Characteristics[NumberOfSamples]": [
      "4 frozen lung squamous cell carcinomas and 4 adjacent tissues"
    ],
    "Characteristics[Organism]": [
      "human entries in UniProt (downloaded 05/25/2015)"
    ],
    "Characteristics[SpikedCompound]": [
      "Twenty-five femtomoles of PRTC was spiked in each LC-MS/MS analysis to monitor instrument performance (Figure S1)."
    ],
    "Comment[Instrument]": [
      "QExactive Plus, Thermo, San Jose, CA"
    ],
    "Comment[FractionationMethod]": [
      "basic pH reversed phase HPLC"
    ],
    "Comment[NumberOfFractions]": [
      "Twelve concatenated fractions were analyzed with LC-MS/MS for the LF and TMT experiments."
    ],
    "Comment[AcquisitionMethod]": [
      "DDA"
    ],
    "Comment[CollisionEnergy]": [
      "the normalized collision energy value was set to 30."
    ],
    "Comment[Separation]": [
      "bRPLC separation"
    ],
    "Comment[GradientTime]": [
      "90-minute gradient"
    ],
    "Comment[FlowRateChromatogram]": [
      "The flow rate on analytical column was 300 nl/min."
    ],
    "Comment[FractionIdentifier]": [
      "bRPLC11"
    ]
  },
  "20150820_Haura-Pilot-TMT2-bRPLC06-2.raw": {
    "Source Name": [
      "20150820_Haura-Pilot-TMT2-bRPLC06-2"
    ],
    "Assay Name": [
      "20150820_Haura-Pilot-TMT2-bRPLC06-2.raw"
    ],
    "Raw Data File": [
      "20150820_Haura-Pilot-TMT2-bRPLC06-2.raw"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin digestion was carried out overnight at 37 \u00b0C"
    ],
    "Characteristics[ReductionReagent]": [
      "reduced with 4.5 mM DTT at 60 \u00b0C for 20 minutes"
    ],
    "Characteristics[AlkylationReagent]": [
      "alkylation with 11 mM iodoacetamide at room temperature for 15 minutes in the dark"
    ],
    "Characteristics[Label]": [
      "TMT 6-plex"
    ],
    "Characteristics[MaterialType]": [
      "Tissue samples were homogenized with a BioPulverizer (Biospec) and resuspended in lysis buffer containing 20 mM HEPES, pH 8.0, 9 M urea, 1 mM sodium orthovanadate, 2.5 mM sodium pyrophosphate, and 1 mM \u03b2-glycerophosphate."
    ],
    "Characteristics[NumberOfSamples]": [
      "4 frozen lung squamous cell carcinomas and 4 adjacent tissues"
    ],
    "Characteristics[Organism]": [
      "human entries in UniProt (downloaded 05/25/2015)"
    ],
    "Characteristics[SpikedCompound]": [
      "Twenty-five femtomoles of PRTC was spiked in each LC-MS/MS analysis to monitor instrument performance (Figure S1)."
    ],
    "Comment[Instrument]": [
      "QExactive Plus, Thermo, San Jose, CA"
    ],
    "Comment[FractionationMethod]": [
      "basic pH reversed phase HPLC"
    ],
    "Comment[NumberOfFractions]": [
      "Twelve concatenated fractions were analyzed with LC-MS/MS for the LF and TMT experiments."
    ],
    "Comment[AcquisitionMethod]": [
      "DDA"
    ],
    "Comment[CollisionEnergy]": [
      "the normalized collision energy value was set to 30."
    ],
    "Comment[Separation]": [
      "bRPLC separation"
    ],
    "Comment[GradientTime]": [
      "90-minute gradient"
    ],
    "Comment[FlowRateChromatogram]": [
      "The flow rate on analytical column was 300 nl/min."
    ],
    "Comment[FractionIdentifier]": [
      "bRPLC06"
    ]
  },
  "20150820_Haura-Pilot-TMT2-bRPLC04-1.raw": {
    "Source Name": [
      "20150820_Haura-Pilot-TMT2-bRPLC04-1"
    ],
    "Assay Name": [
      "20150820_Haura-Pilot-TMT2-bRPLC04-1.raw"
    ],
    "Raw Data File": [
      "20150820_Haura-Pilot-TMT2-bRPLC04-1.raw"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin digestion was carried out overnight at 37 \u00b0C"
    ],
    "Characteristics[ReductionReagent]": [
      "reduced with 4.5 mM DTT at 60 \u00b0C for 20 minutes"
    ],
    "Characteristics[AlkylationReagent]": [
      "alkylation with 11 mM iodoacetamide at room temperature for 15 minutes in the dark"
    ],
    "Characteristics[Label]": [
      "TMT 6-plex"
    ],
    "Characteristics[MaterialType]": [
      "Tissue samples were homogenized with a BioPulverizer (Biospec) and resuspended in lysis buffer containing 20 mM HEPES, pH 8.0, 9 M urea, 1 mM sodium orthovanadate, 2.5 mM sodium pyrophosphate, and 1 mM \u03b2-glycerophosphate."
    ],
    "Characteristics[NumberOfSamples]": [
      "4 frozen lung squamous cell carcinomas and 4 adjacent tissues"
    ],
    "Characteristics[Organism]": [
      "human entries in UniProt (downloaded 05/25/2015)"
    ],
    "Characteristics[SpikedCompound]": [
      "Twenty-five femtomoles of PRTC was spiked in each LC-MS/MS analysis to monitor instrument performance (Figure S1)."
    ],
    "Comment[Instrument]": [
      "QExactive Plus, Thermo, San Jose, CA"
    ],
    "Comment[FractionationMethod]": [
      "basic pH reversed phase HPLC"
    ],
    "Comment[NumberOfFractions]": [
      "Twelve concatenated fractions were analyzed with LC-MS/MS for the LF and TMT experiments."
    ],
    "Comment[AcquisitionMethod]": [
      "DDA"
    ],
    "Comment[CollisionEnergy]": [
      "the normalized collision energy value was set to 30."
    ],
    "Comment[Separation]": [
      "bRPLC separation"
    ],
    "Comment[GradientTime]": [
      "90-minute gradient"
    ],
    "Comment[FlowRateChromatogram]": [
      "The flow rate on analytical column was 300 nl/min."
    ],
    "Comment[FractionIdentifier]": [
      "bRPLC04"
    ]
  },
  "20150820_Haura-Pilot-TMT1-bRPLC03-2.raw": {
    "Source Name": [
      "20150820_Haura-Pilot-TMT1-bRPLC03-2"
    ],
    "Assay Name": [
      "20150820_Haura-Pilot-TMT1-bRPLC03-2.raw"
    ],
    "Raw Data File": [
      "20150820_Haura-Pilot-TMT1-bRPLC03-2.raw"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin digestion was carried out overnight at 37 \u00b0C"
    ],
    "Characteristics[ReductionReagent]": [
      "reduced with 4.5 mM DTT at 60 \u00b0C for 20 minutes"
    ],
    "Characteristics[AlkylationReagent]": [
      "alkylation with 11 mM iodoacetamide at room temperature for 15 minutes in the dark"
    ],
    "Characteristics[Label]": [
      "TMT 6-plex"
    ],
    "Characteristics[MaterialType]": [
      "Tissue samples were homogenized with a BioPulverizer (Biospec) and resuspended in lysis buffer containing 20 mM HEPES, pH 8.0, 9 M urea, 1 mM sodium orthovanadate, 2.5 mM sodium pyrophosphate, and 1 mM \u03b2-glycerophosphate."
    ],
    "Characteristics[NumberOfSamples]": [
      "4 frozen lung squamous cell carcinomas and 4 adjacent tissues"
    ],
    "Characteristics[Organism]": [
      "human entries in UniProt (downloaded 05/25/2015)"
    ],
    "Characteristics[SpikedCompound]": [
      "Twenty-five femtomoles of PRTC was spiked in each LC-MS/MS analysis to monitor instrument performance (Figure S1)."
    ],
    "Comment[Instrument]": [
      "QExactive Plus, Thermo, San Jose, CA"
    ],
    "Comment[FractionationMethod]": [
      "basic pH reversed phase HPLC"
    ],
    "Comment[NumberOfFractions]": [
      "Twelve concatenated fractions were analyzed with LC-MS/MS for the LF and TMT experiments."
    ],
    "Comment[AcquisitionMethod]": [
      "DDA"
    ],
    "Comment[CollisionEnergy]": [
      "the normalized collision energy value was set to 30."
    ],
    "Comment[Separation]": [
      "bRPLC separation"
    ],
    "Comment[GradientTime]": [
      "90-minute gradient"
    ],
    "Comment[FlowRateChromatogram]": [
      "The flow rate on analytical column was 300 nl/min."
    ],
    "Comment[FractionIdentifier]": [
      "bRPLC03"
    ]
  },
  "20150820_Haura-Pilot-TMT1-bRPLC09-1.raw": {
    "Source Name": [
      "20150820_Haura-Pilot-TMT1-bRPLC09-1"
    ],
    "Assay Name": [
      "20150820_Haura-Pilot-TMT1-bRPLC09-1.raw"
    ],
    "Raw Data File": [
      "20150820_Haura-Pilot-TMT1-bRPLC09-1.raw"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin digestion was carried out overnight at 37 \u00b0C"
    ],
    "Characteristics[ReductionReagent]": [
      "reduced with 4.5 mM DTT at 60 \u00b0C for 20 minutes"
    ],
    "Characteristics[AlkylationReagent]": [
      "alkylation with 11 mM iodoacetamide at room temperature for 15 minutes in the dark"
    ],
    "Characteristics[Label]": [
      "TMT 6-plex"
    ],
    "Characteristics[MaterialType]": [
      "Tissue samples were homogenized with a BioPulverizer (Biospec) and resuspended in lysis buffer containing 20 mM HEPES, pH 8.0, 9 M urea, 1 mM sodium orthovanadate, 2.5 mM sodium pyrophosphate, and 1 mM \u03b2-glycerophosphate."
    ],
    "Characteristics[NumberOfSamples]": [
      "4 frozen lung squamous cell carcinomas and 4 adjacent tissues"
    ],
    "Characteristics[Organism]": [
      "human entries in UniProt (downloaded 05/25/2015)"
    ],
    "Characteristics[SpikedCompound]": [
      "Twenty-five femtomoles of PRTC was spiked in each LC-MS/MS analysis to monitor instrument performance (Figure S1)."
    ],
    "Comment[Instrument]": [
      "QExactive Plus, Thermo, San Jose, CA"
    ],
    "Comment[FractionationMethod]": [
      "basic pH reversed phase HPLC"
    ],
    "Comment[NumberOfFractions]": [
      "Twelve concatenated fractions were analyzed with LC-MS/MS for the LF and TMT experiments."
    ],
    "Comment[AcquisitionMethod]": [
      "DDA"
    ],
    "Comment[CollisionEnergy]": [
      "the normalized collision energy value was set to 30."
    ],
    "Comment[Separation]": [
      "bRPLC separation"
    ],
    "Comment[GradientTime]": [
      "90-minute gradient"
    ],
    "Comment[FlowRateChromatogram]": [
      "The flow rate on analytical column was 300 nl/min."
    ],
    "Comment[FractionIdentifier]": [
      "bRPLC09"
    ]
  },
  "20150820_Haura-Pilot-TMT2-bRPLC04-2.raw": {
    "Source Name": [
      "20150820_Haura-Pilot-TMT2-bRPLC04-2"
    ],
    "Assay Name": [
      "20150820_Haura-Pilot-TMT2-bRPLC04-2.raw"
    ],
    "Raw Data File": [
      "20150820_Haura-Pilot-TMT2-bRPLC04-2.raw"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin digestion was carried out overnight at 37 \u00b0C"
    ],
    "Characteristics[ReductionReagent]": [
      "reduced with 4.5 mM DTT at 60 \u00b0C for 20 minutes"
    ],
    "Characteristics[AlkylationReagent]": [
      "alkylation with 11 mM iodoacetamide at room temperature for 15 minutes in the dark"
    ],
    "Characteristics[Label]": [
      "TMT 6-plex"
    ],
    "Characteristics[MaterialType]": [
      "Tissue samples were homogenized with a BioPulverizer (Biospec) and resuspended in lysis buffer containing 20 mM HEPES, pH 8.0, 9 M urea, 1 mM sodium orthovanadate, 2.5 mM sodium pyrophosphate, and 1 mM \u03b2-glycerophosphate."
    ],
    "Characteristics[NumberOfSamples]": [
      "4 frozen lung squamous cell carcinomas and 4 adjacent tissues"
    ],
    "Characteristics[Organism]": [
      "human entries in UniProt (downloaded 05/25/2015)"
    ],
    "Characteristics[SpikedCompound]": [
      "Twenty-five femtomoles of PRTC was spiked in each LC-MS/MS analysis to monitor instrument performance (Figure S1)."
    ],
    "Comment[Instrument]": [
      "QExactive Plus, Thermo, San Jose, CA"
    ],
    "Comment[FractionationMethod]": [
      "basic pH reversed phase HPLC"
    ],
    "Comment[NumberOfFractions]": [
      "Twelve concatenated fractions were analyzed with LC-MS/MS for the LF and TMT experiments."
    ],
    "Comment[AcquisitionMethod]": [
      "DDA"
    ],
    "Comment[CollisionEnergy]": [
      "the normalized collision energy value was set to 30."
    ],
    "Comment[Separation]": [
      "bRPLC separation"
    ],
    "Comment[GradientTime]": [
      "90-minute gradient"
    ],
    "Comment[FlowRateChromatogram]": [
      "The flow rate on analytical column was 300 nl/min."
    ],
    "Comment[FractionIdentifier]": [
      "bRPLC04"
    ]
  },
  "20150820_Haura-Pilot-TMT2-bRPLC06-1.raw": {
    "Source Name": [
      "20150820_Haura-Pilot-TMT2-bRPLC06-1"
    ],
    "Assay Name": [
      "20150820_Haura-Pilot-TMT2-bRPLC06-1.raw"
    ],
    "Raw Data File": [
      "20150820_Haura-Pilot-TMT2-bRPLC06-1.raw"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin digestion was carried out overnight at 37 \u00b0C"
    ],
    "Characteristics[ReductionReagent]": [
      "reduced with 4.5 mM DTT at 60 \u00b0C for 20 minutes"
    ],
    "Characteristics[AlkylationReagent]": [
      "alkylation with 11 mM iodoacetamide at room temperature for 15 minutes in the dark"
    ],
    "Characteristics[Label]": [
      "TMT 6-plex"
    ],
    "Characteristics[MaterialType]": [
      "Tissue samples were homogenized with a BioPulverizer (Biospec) and resuspended in lysis buffer containing 20 mM HEPES, pH 8.0, 9 M urea, 1 mM sodium orthovanadate, 2.5 mM sodium pyrophosphate, and 1 mM \u03b2-glycerophosphate."
    ],
    "Characteristics[NumberOfSamples]": [
      "4 frozen lung squamous cell carcinomas and 4 adjacent tissues"
    ],
    "Characteristics[Organism]": [
      "human entries in UniProt (downloaded 05/25/2015)"
    ],
    "Characteristics[SpikedCompound]": [
      "Twenty-five femtomoles of PRTC was spiked in each LC-MS/MS analysis to monitor instrument performance (Figure S1)."
    ],
    "Comment[Instrument]": [
      "QExactive Plus, Thermo, San Jose, CA"
    ],
    "Comment[FractionationMethod]": [
      "basic pH reversed phase HPLC"
    ],
    "Comment[NumberOfFractions]": [
      "Twelve concatenated fractions were analyzed with LC-MS/MS for the LF and TMT experiments."
    ],
    "Comment[AcquisitionMethod]": [
      "DDA"
    ],
    "Comment[CollisionEnergy]": [
      "the normalized collision energy value was set to 30."
    ],
    "Comment[Separation]": [
      "bRPLC separation"
    ],
    "Comment[GradientTime]": [
      "90-minute gradient"
    ],
    "Comment[FlowRateChromatogram]": [
      "The flow rate on analytical column was 300 nl/min."
    ],
    "Comment[FractionIdentifier]": [
      "bRPLC06"
    ]
  },
  "20150820_Haura-Pilot-TMT1-bRPLC05-1.raw": {
    "Source Name": [
      "20150820_Haura-Pilot-TMT1-bRPLC05-1"
    ],
    "Assay Name": [
      "20150820_Haura-Pilot-TMT1-bRPLC05-1.raw"
    ],
    "Raw Data File": [
      "20150820_Haura-Pilot-TMT1-bRPLC05-1.raw"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin digestion was carried out overnight at 37 \u00b0C"
    ],
    "Characteristics[ReductionReagent]": [
      "reduced with 4.5 mM DTT at 60 \u00b0C for 20 minutes"
    ],
    "Characteristics[AlkylationReagent]": [
      "alkylation with 11 mM iodoacetamide at room temperature for 15 minutes in the dark"
    ],
    "Characteristics[Label]": [
      "TMT 6-plex"
    ],
    "Characteristics[MaterialType]": [
      "Tissue samples were homogenized with a BioPulverizer (Biospec) and resuspended in lysis buffer containing 20 mM HEPES, pH 8.0, 9 M urea, 1 mM sodium orthovanadate, 2.5 mM sodium pyrophosphate, and 1 mM \u03b2-glycerophosphate."
    ],
    "Characteristics[NumberOfSamples]": [
      "4 frozen lung squamous cell carcinomas and 4 adjacent tissues"
    ],
    "Characteristics[Organism]": [
      "human entries in UniProt (downloaded 05/25/2015)"
    ],
    "Characteristics[SpikedCompound]": [
      "Twenty-five femtomoles of PRTC was spiked in each LC-MS/MS analysis to monitor instrument performance (Figure S1)."
    ],
    "Comment[Instrument]": [
      "QExactive Plus, Thermo, San Jose, CA"
    ],
    "Comment[FractionationMethod]": [
      "basic pH reversed phase HPLC"
    ],
    "Comment[NumberOfFractions]": [
      "Twelve concatenated fractions were analyzed with LC-MS/MS for the LF and TMT experiments."
    ],
    "Comment[AcquisitionMethod]": [
      "DDA"
    ],
    "Comment[CollisionEnergy]": [
      "the normalized collision energy value was set to 30."
    ],
    "Comment[Separation]": [
      "bRPLC separation"
    ],
    "Comment[GradientTime]": [
      "90-minute gradient"
    ],
    "Comment[FlowRateChromatogram]": [
      "The flow rate on analytical column was 300 nl/min."
    ],
    "Comment[FractionIdentifier]": [
      "bRPLC05"
    ]
  },
  "20150820_Haura-Pilot-TMT2-bRPLC08-1.raw": {
    "Source Name": [
      "20150820_Haura-Pilot-TMT2-bRPLC08-1"
    ],
    "Assay Name": [
      "20150820_Haura-Pilot-TMT2-bRPLC08-1.raw"
    ],
    "Raw Data File": [
      "20150820_Haura-Pilot-TMT2-bRPLC08-1.raw"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin digestion was carried out overnight at 37 \u00b0C"
    ],
    "Characteristics[ReductionReagent]": [
      "reduced with 4.5 mM DTT at 60 \u00b0C for 20 minutes"
    ],
    "Characteristics[AlkylationReagent]": [
      "alkylation with 11 mM iodoacetamide at room temperature for 15 minutes in the dark"
    ],
    "Characteristics[Label]": [
      "TMT 6-plex"
    ],
    "Characteristics[MaterialType]": [
      "Tissue samples were homogenized with a BioPulverizer (Biospec) and resuspended in lysis buffer containing 20 mM HEPES, pH 8.0, 9 M urea, 1 mM sodium orthovanadate, 2.5 mM sodium pyrophosphate, and 1 mM \u03b2-glycerophosphate."
    ],
    "Characteristics[NumberOfSamples]": [
      "4 frozen lung squamous cell carcinomas and 4 adjacent tissues"
    ],
    "Characteristics[Organism]": [
      "human entries in UniProt (downloaded 05/25/2015)"
    ],
    "Characteristics[SpikedCompound]": [
      "Twenty-five femtomoles of PRTC was spiked in each LC-MS/MS analysis to monitor instrument performance (Figure S1)."
    ],
    "Comment[Instrument]": [
      "QExactive Plus, Thermo, San Jose, CA"
    ],
    "Comment[FractionationMethod]": [
      "basic pH reversed phase HPLC"
    ],
    "Comment[NumberOfFractions]": [
      "Twelve concatenated fractions were analyzed with LC-MS/MS for the LF and TMT experiments."
    ],
    "Comment[AcquisitionMethod]": [
      "DDA"
    ],
    "Comment[CollisionEnergy]": [
      "the normalized collision energy value was set to 30."
    ],
    "Comment[Separation]": [
      "bRPLC separation"
    ],
    "Comment[GradientTime]": [
      "90-minute gradient"
    ],
    "Comment[FlowRateChromatogram]": [
      "The flow rate on analytical column was 300 nl/min."
    ],
    "Comment[FractionIdentifier]": [
      "bRPLC08"
    ]
  },
  "20150820_Haura-Pilot-TMT2-bRPLC02-1.raw": {
    "Source Name": [
      "20150820_Haura-Pilot-TMT2-bRPLC02-1"
    ],
    "Assay Name": [
      "20150820_Haura-Pilot-TMT2-bRPLC02-1.raw"
    ],
    "Raw Data File": [
      "20150820_Haura-Pilot-TMT2-bRPLC02-1.raw"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin digestion was carried out overnight at 37 \u00b0C"
    ],
    "Characteristics[ReductionReagent]": [
      "reduced with 4.5 mM DTT at 60 \u00b0C for 20 minutes"
    ],
    "Characteristics[AlkylationReagent]": [
      "alkylation with 11 mM iodoacetamide at room temperature for 15 minutes in the dark"
    ],
    "Characteristics[Label]": [
      "TMT 6-plex"
    ],
    "Characteristics[MaterialType]": [
      "Tissue samples were homogenized with a BioPulverizer (Biospec) and resuspended in lysis buffer containing 20 mM HEPES, pH 8.0, 9 M urea, 1 mM sodium orthovanadate, 2.5 mM sodium pyrophosphate, and 1 mM \u03b2-glycerophosphate."
    ],
    "Characteristics[NumberOfSamples]": [
      "4 frozen lung squamous cell carcinomas and 4 adjacent tissues"
    ],
    "Characteristics[Organism]": [
      "human entries in UniProt (downloaded 05/25/2015)"
    ],
    "Characteristics[SpikedCompound]": [
      "Twenty-five femtomoles of PRTC was spiked in each LC-MS/MS analysis to monitor instrument performance (Figure S1)."
    ],
    "Comment[Instrument]": [
      "QExactive Plus, Thermo, San Jose, CA"
    ],
    "Comment[FractionationMethod]": [
      "basic pH reversed phase HPLC"
    ],
    "Comment[NumberOfFractions]": [
      "Twelve concatenated fractions were analyzed with LC-MS/MS for the LF and TMT experiments."
    ],
    "Comment[AcquisitionMethod]": [
      "DDA"
    ],
    "Comment[CollisionEnergy]": [
      "the normalized collision energy value was set to 30."
    ],
    "Comment[Separation]": [
      "bRPLC separation"
    ],
    "Comment[GradientTime]": [
      "90-minute gradient"
    ],
    "Comment[FlowRateChromatogram]": [
      "The flow rate on analytical column was 300 nl/min."
    ],
    "Comment[FractionIdentifier]": [
      "bRPLC02"
    ]
  },
  "20150820_Haura-Pilot-TMT1-bRPLC07-2.raw": {
    "Source Name": [
      "20150820_Haura-Pilot-TMT1-bRPLC07-2"
    ],
    "Assay Name": [
      "20150820_Haura-Pilot-TMT1-bRPLC07-2.raw"
    ],
    "Raw Data File": [
      "20150820_Haura-Pilot-TMT1-bRPLC07-2.raw"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin digestion was carried out overnight at 37 \u00b0C"
    ],
    "Characteristics[ReductionReagent]": [
      "reduced with 4.5 mM DTT at 60 \u00b0C for 20 minutes"
    ],
    "Characteristics[AlkylationReagent]": [
      "alkylation with 11 mM iodoacetamide at room temperature for 15 minutes in the dark"
    ],
    "Characteristics[Label]": [
      "TMT 6-plex"
    ],
    "Characteristics[MaterialType]": [
      "Tissue samples were homogenized with a BioPulverizer (Biospec) and resuspended in lysis buffer containing 20 mM HEPES, pH 8.0, 9 M urea, 1 mM sodium orthovanadate, 2.5 mM sodium pyrophosphate, and 1 mM \u03b2-glycerophosphate."
    ],
    "Characteristics[NumberOfSamples]": [
      "4 frozen lung squamous cell carcinomas and 4 adjacent tissues"
    ],
    "Characteristics[Organism]": [
      "human entries in UniProt (downloaded 05/25/2015)"
    ],
    "Characteristics[SpikedCompound]": [
      "Twenty-five femtomoles of PRTC was spiked in each LC-MS/MS analysis to monitor instrument performance (Figure S1)."
    ],
    "Comment[Instrument]": [
      "QExactive Plus, Thermo, San Jose, CA"
    ],
    "Comment[FractionationMethod]": [
      "basic pH reversed phase HPLC"
    ],
    "Comment[NumberOfFractions]": [
      "Twelve concatenated fractions were analyzed with LC-MS/MS for the LF and TMT experiments."
    ],
    "Comment[AcquisitionMethod]": [
      "DDA"
    ],
    "Comment[CollisionEnergy]": [
      "the normalized collision energy value was set to 30."
    ],
    "Comment[Separation]": [
      "bRPLC separation"
    ],
    "Comment[GradientTime]": [
      "90-minute gradient"
    ],
    "Comment[FlowRateChromatogram]": [
      "The flow rate on analytical column was 300 nl/min."
    ],
    "Comment[FractionIdentifier]": [
      "bRPLC07"
    ]
  },
  "20150820_Haura-Pilot-TMT1-bRPLC12-2.raw": {
    "Source Name": [
      "20150820_Haura-Pilot-TMT1-bRPLC12-2"
    ],
    "Assay Name": [
      "20150820_Haura-Pilot-TMT1-bRPLC12-2.raw"
    ],
    "Raw Data File": [
      "20150820_Haura-Pilot-TMT1-bRPLC12-2.raw"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin digestion was carried out overnight at 37 \u00b0C"
    ],
    "Characteristics[ReductionReagent]": [
      "reduced with 4.5 mM DTT at 60 \u00b0C for 20 minutes"
    ],
    "Characteristics[AlkylationReagent]": [
      "alkylation with 11 mM iodoacetamide at room temperature for 15 minutes in the dark"
    ],
    "Characteristics[Label]": [
      "TMT 6-plex"
    ],
    "Characteristics[MaterialType]": [
      "Tissue samples were homogenized with a BioPulverizer (Biospec) and resuspended in lysis buffer containing 20 mM HEPES, pH 8.0, 9 M urea, 1 mM sodium orthovanadate, 2.5 mM sodium pyrophosphate, and 1 mM \u03b2-glycerophosphate."
    ],
    "Characteristics[NumberOfSamples]": [
      "4 frozen lung squamous cell carcinomas and 4 adjacent tissues"
    ],
    "Characteristics[Organism]": [
      "human entries in UniProt (downloaded 05/25/2015)"
    ],
    "Characteristics[SpikedCompound]": [
      "Twenty-five femtomoles of PRTC was spiked in each LC-MS/MS analysis to monitor instrument performance (Figure S1)."
    ],
    "Comment[Instrument]": [
      "QExactive Plus, Thermo, San Jose, CA"
    ],
    "Comment[FractionationMethod]": [
      "basic pH reversed phase HPLC"
    ],
    "Comment[NumberOfFractions]": [
      "Twelve concatenated fractions were analyzed with LC-MS/MS for the LF and TMT experiments."
    ],
    "Comment[AcquisitionMethod]": [
      "DDA"
    ],
    "Comment[CollisionEnergy]": [
      "the normalized collision energy value was set to 30."
    ],
    "Comment[Separation]": [
      "bRPLC separation"
    ],
    "Comment[GradientTime]": [
      "90-minute gradient"
    ],
    "Comment[FlowRateChromatogram]": [
      "The flow rate on analytical column was 300 nl/min."
    ],
    "Comment[FractionIdentifier]": [
      "bRPLC12"
    ]
  },
  "20150820_Haura-Pilot-TMT1-bRPLC12-1.raw": {
    "Source Name": [
      "20150820_Haura-Pilot-TMT1-bRPLC12-1"
    ],
    "Assay Name": [
      "20150820_Haura-Pilot-TMT1-bRPLC12-1.raw"
    ],
    "Raw Data File": [
      "20150820_Haura-Pilot-TMT1-bRPLC12-1.raw"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin digestion was carried out overnight at 37 \u00b0C"
    ],
    "Characteristics[ReductionReagent]": [
      "reduced with 4.5 mM DTT at 60 \u00b0C for 20 minutes"
    ],
    "Characteristics[AlkylationReagent]": [
      "alkylation with 11 mM iodoacetamide at room temperature for 15 minutes in the dark"
    ],
    "Characteristics[Label]": [
      "TMT 6-plex"
    ],
    "Characteristics[MaterialType]": [
      "Tissue samples were homogenized with a BioPulverizer (Biospec) and resuspended in lysis buffer containing 20 mM HEPES, pH 8.0, 9 M urea, 1 mM sodium orthovanadate, 2.5 mM sodium pyrophosphate, and 1 mM \u03b2-glycerophosphate."
    ],
    "Characteristics[NumberOfSamples]": [
      "4 frozen lung squamous cell carcinomas and 4 adjacent tissues"
    ],
    "Characteristics[Organism]": [
      "human entries in UniProt (downloaded 05/25/2015)"
    ],
    "Characteristics[SpikedCompound]": [
      "Twenty-five femtomoles of PRTC was spiked in each LC-MS/MS analysis to monitor instrument performance (Figure S1)."
    ],
    "Comment[Instrument]": [
      "QExactive Plus, Thermo, San Jose, CA"
    ],
    "Comment[FractionationMethod]": [
      "basic pH reversed phase HPLC"
    ],
    "Comment[NumberOfFractions]": [
      "Twelve concatenated fractions were analyzed with LC-MS/MS for the LF and TMT experiments."
    ],
    "Comment[AcquisitionMethod]": [
      "DDA"
    ],
    "Comment[CollisionEnergy]": [
      "the normalized collision energy value was set to 30."
    ],
    "Comment[Separation]": [
      "bRPLC separation"
    ],
    "Comment[GradientTime]": [
      "90-minute gradient"
    ],
    "Comment[FlowRateChromatogram]": [
      "The flow rate on analytical column was 300 nl/min."
    ],
    "Comment[FractionIdentifier]": [
      "bRPLC12"
    ]
  },
  "20150820_Haura-Pilot-TMT2-bRPLC11-2.raw": {
    "Source Name": [
      "20150820_Haura-Pilot-TMT2-bRPLC11-2"
    ],
    "Assay Name": [
      "20150820_Haura-Pilot-TMT2-bRPLC11-2.raw"
    ],
    "Raw Data File": [
      "20150820_Haura-Pilot-TMT2-bRPLC11-2.raw"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin digestion was carried out overnight at 37 \u00b0C"
    ],
    "Characteristics[ReductionReagent]": [
      "reduced with 4.5 mM DTT at 60 \u00b0C for 20 minutes"
    ],
    "Characteristics[AlkylationReagent]": [
      "alkylation with 11 mM iodoacetamide at room temperature for 15 minutes in the dark"
    ],
    "Characteristics[Label]": [
      "TMT 6-plex"
    ],
    "Characteristics[MaterialType]": [
      "Tissue samples were homogenized with a BioPulverizer (Biospec) and resuspended in lysis buffer containing 20 mM HEPES, pH 8.0, 9 M urea, 1 mM sodium orthovanadate, 2.5 mM sodium pyrophosphate, and 1 mM \u03b2-glycerophosphate."
    ],
    "Characteristics[NumberOfSamples]": [
      "4 frozen lung squamous cell carcinomas and 4 adjacent tissues"
    ],
    "Characteristics[Organism]": [
      "human entries in UniProt (downloaded 05/25/2015)"
    ],
    "Characteristics[SpikedCompound]": [
      "Twenty-five femtomoles of PRTC was spiked in each LC-MS/MS analysis to monitor instrument performance (Figure S1)."
    ],
    "Comment[Instrument]": [
      "QExactive Plus, Thermo, San Jose, CA"
    ],
    "Comment[FractionationMethod]": [
      "basic pH reversed phase HPLC"
    ],
    "Comment[NumberOfFractions]": [
      "Twelve concatenated fractions were analyzed with LC-MS/MS for the LF and TMT experiments."
    ],
    "Comment[AcquisitionMethod]": [
      "DDA"
    ],
    "Comment[CollisionEnergy]": [
      "the normalized collision energy value was set to 30."
    ],
    "Comment[Separation]": [
      "bRPLC separation"
    ],
    "Comment[GradientTime]": [
      "90-minute gradient"
    ],
    "Comment[FlowRateChromatogram]": [
      "The flow rate on analytical column was 300 nl/min."
    ],
    "Comment[FractionIdentifier]": [
      "bRPLC11"
    ]
  },
  "20150820_Haura-Pilot-TMT1-bRPLC01-1.raw": {
    "Source Name": [
      "20150820_Haura-Pilot-TMT1-bRPLC01-1"
    ],
    "Assay Name": [
      "20150820_Haura-Pilot-TMT1-bRPLC01-1.raw"
    ],
    "Raw Data File": [
      "20150820_Haura-Pilot-TMT1-bRPLC01-1.raw"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin digestion was carried out overnight at 37 \u00b0C"
    ],
    "Characteristics[ReductionReagent]": [
      "reduced with 4.5 mM DTT at 60 \u00b0C for 20 minutes"
    ],
    "Characteristics[AlkylationReagent]": [
      "alkylation with 11 mM iodoacetamide at room temperature for 15 minutes in the dark"
    ],
    "Characteristics[Label]": [
      "TMT 6-plex"
    ],
    "Characteristics[MaterialType]": [
      "Tissue samples were homogenized with a BioPulverizer (Biospec) and resuspended in lysis buffer containing 20 mM HEPES, pH 8.0, 9 M urea, 1 mM sodium orthovanadate, 2.5 mM sodium pyrophosphate, and 1 mM \u03b2-glycerophosphate."
    ],
    "Characteristics[NumberOfSamples]": [
      "4 frozen lung squamous cell carcinomas and 4 adjacent tissues"
    ],
    "Characteristics[Organism]": [
      "human entries in UniProt (downloaded 05/25/2015)"
    ],
    "Characteristics[SpikedCompound]": [
      "Twenty-five femtomoles of PRTC was spiked in each LC-MS/MS analysis to monitor instrument performance (Figure S1)."
    ],
    "Comment[Instrument]": [
      "QExactive Plus, Thermo, San Jose, CA"
    ],
    "Comment[FractionationMethod]": [
      "basic pH reversed phase HPLC"
    ],
    "Comment[NumberOfFractions]": [
      "Twelve concatenated fractions were analyzed with LC-MS/MS for the LF and TMT experiments."
    ],
    "Comment[AcquisitionMethod]": [
      "DDA"
    ],
    "Comment[CollisionEnergy]": [
      "the normalized collision energy value was set to 30."
    ],
    "Comment[Separation]": [
      "bRPLC separation"
    ],
    "Comment[GradientTime]": [
      "90-minute gradient"
    ],
    "Comment[FlowRateChromatogram]": [
      "The flow rate on analytical column was 300 nl/min."
    ],
    "Comment[FractionIdentifier]": [
      "bRPLC01"
    ]
  },
  "20150820_Haura-Pilot-TMT2-bRPLC10-1.raw": {
    "Source Name": [
      "20150820_Haura-Pilot-TMT2-bRPLC10-1"
    ],
    "Assay Name": [
      "20150820_Haura-Pilot-TMT2-bRPLC10-1.raw"
    ],
    "Raw Data File": [
      "20150820_Haura-Pilot-TMT2-bRPLC10-1.raw"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin digestion was carried out overnight at 37 \u00b0C"
    ],
    "Characteristics[ReductionReagent]": [
      "reduced with 4.5 mM DTT at 60 \u00b0C for 20 minutes"
    ],
    "Characteristics[AlkylationReagent]": [
      "alkylation with 11 mM iodoacetamide at room temperature for 15 minutes in the dark"
    ],
    "Characteristics[Label]": [
      "TMT 6-plex"
    ],
    "Characteristics[MaterialType]": [
      "Tissue samples were homogenized with a BioPulverizer (Biospec) and resuspended in lysis buffer containing 20 mM HEPES, pH 8.0, 9 M urea, 1 mM sodium orthovanadate, 2.5 mM sodium pyrophosphate, and 1 mM \u03b2-glycerophosphate."
    ],
    "Characteristics[NumberOfSamples]": [
      "4 frozen lung squamous cell carcinomas and 4 adjacent tissues"
    ],
    "Characteristics[Organism]": [
      "human entries in UniProt (downloaded 05/25/2015)"
    ],
    "Characteristics[SpikedCompound]": [
      "Twenty-five femtomoles of PRTC was spiked in each LC-MS/MS analysis to monitor instrument performance (Figure S1)."
    ],
    "Comment[Instrument]": [
      "QExactive Plus, Thermo, San Jose, CA"
    ],
    "Comment[FractionationMethod]": [
      "basic pH reversed phase HPLC"
    ],
    "Comment[NumberOfFractions]": [
      "Twelve concatenated fractions were analyzed with LC-MS/MS for the LF and TMT experiments."
    ],
    "Comment[AcquisitionMethod]": [
      "DDA"
    ],
    "Comment[CollisionEnergy]": [
      "the normalized collision energy value was set to 30."
    ],
    "Comment[Separation]": [
      "bRPLC separation"
    ],
    "Comment[GradientTime]": [
      "90-minute gradient"
    ],
    "Comment[FlowRateChromatogram]": [
      "The flow rate on analytical column was 300 nl/min."
    ],
    "Comment[FractionIdentifier]": [
      "bRPLC10"
    ]
  },
  "20150820_Haura-Pilot-TMT2-bRPLC05-2.raw": {
    "Source Name": [
      "20150820_Haura-Pilot-TMT2-bRPLC05-2"
    ],
    "Assay Name": [
      "20150820_Haura-Pilot-TMT2-bRPLC05-2.raw"
    ],
    "Raw Data File": [
      "20150820_Haura-Pilot-TMT2-bRPLC05-2.raw"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin digestion was carried out overnight at 37 \u00b0C"
    ],
    "Characteristics[ReductionReagent]": [
      "reduced with 4.5 mM DTT at 60 \u00b0C for 20 minutes"
    ],
    "Characteristics[AlkylationReagent]": [
      "alkylation with 11 mM iodoacetamide at room temperature for 15 minutes in the dark"
    ],
    "Characteristics[Label]": [
      "TMT 6-plex"
    ],
    "Characteristics[MaterialType]": [
      "Tissue samples were homogenized with a BioPulverizer (Biospec) and resuspended in lysis buffer containing 20 mM HEPES, pH 8.0, 9 M urea, 1 mM sodium orthovanadate, 2.5 mM sodium pyrophosphate, and 1 mM \u03b2-glycerophosphate."
    ],
    "Characteristics[NumberOfSamples]": [
      "4 frozen lung squamous cell carcinomas and 4 adjacent tissues"
    ],
    "Characteristics[Organism]": [
      "human entries in UniProt (downloaded 05/25/2015)"
    ],
    "Characteristics[SpikedCompound]": [
      "Twenty-five femtomoles of PRTC was spiked in each LC-MS/MS analysis to monitor instrument performance (Figure S1)."
    ],
    "Comment[Instrument]": [
      "QExactive Plus, Thermo, San Jose, CA"
    ],
    "Comment[FractionationMethod]": [
      "basic pH reversed phase HPLC"
    ],
    "Comment[NumberOfFractions]": [
      "Twelve concatenated fractions were analyzed with LC-MS/MS for the LF and TMT experiments."
    ],
    "Comment[AcquisitionMethod]": [
      "DDA"
    ],
    "Comment[CollisionEnergy]": [
      "the normalized collision energy value was set to 30."
    ],
    "Comment[Separation]": [
      "bRPLC separation"
    ],
    "Comment[GradientTime]": [
      "90-minute gradient"
    ],
    "Comment[FlowRateChromatogram]": [
      "The flow rate on analytical column was 300 nl/min."
    ],
    "Comment[FractionIdentifier]": [
      "bRPLC05"
    ]
  },
  "20150820_Haura-Pilot-TMT2-bRPLC10-2.raw": {
    "Source Name": [
      "20150820_Haura-Pilot-TMT2-bRPLC10-2"
    ],
    "Assay Name": [
      "20150820_Haura-Pilot-TMT2-bRPLC10-2.raw"
    ],
    "Raw Data File": [
      "20150820_Haura-Pilot-TMT2-bRPLC10-2.raw"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin digestion was carried out overnight at 37 \u00b0C"
    ],
    "Characteristics[ReductionReagent]": [
      "reduced with 4.5 mM DTT at 60 \u00b0C for 20 minutes"
    ],
    "Characteristics[AlkylationReagent]": [
      "alkylation with 11 mM iodoacetamide at room temperature for 15 minutes in the dark"
    ],
    "Characteristics[Label]": [
      "TMT 6-plex"
    ],
    "Characteristics[MaterialType]": [
      "Tissue samples were homogenized with a BioPulverizer (Biospec) and resuspended in lysis buffer containing 20 mM HEPES, pH 8.0, 9 M urea, 1 mM sodium orthovanadate, 2.5 mM sodium pyrophosphate, and 1 mM \u03b2-glycerophosphate."
    ],
    "Characteristics[NumberOfSamples]": [
      "4 frozen lung squamous cell carcinomas and 4 adjacent tissues"
    ],
    "Characteristics[Organism]": [
      "human entries in UniProt (downloaded 05/25/2015)"
    ],
    "Characteristics[SpikedCompound]": [
      "Twenty-five femtomoles of PRTC was spiked in each LC-MS/MS analysis to monitor instrument performance (Figure S1)."
    ],
    "Comment[Instrument]": [
      "QExactive Plus, Thermo, San Jose, CA"
    ],
    "Comment[FractionationMethod]": [
      "basic pH reversed phase HPLC"
    ],
    "Comment[NumberOfFractions]": [
      "Twelve concatenated fractions were analyzed with LC-MS/MS for the LF and TMT experiments."
    ],
    "Comment[AcquisitionMethod]": [
      "DDA"
    ],
    "Comment[CollisionEnergy]": [
      "the normalized collision energy value was set to 30."
    ],
    "Comment[Separation]": [
      "bRPLC separation"
    ],
    "Comment[GradientTime]": [
      "90-minute gradient"
    ],
    "Comment[FlowRateChromatogram]": [
      "The flow rate on analytical column was 300 nl/min."
    ],
    "Comment[FractionIdentifier]": [
      "bRPLC10"
    ]
  },
  "20150820_Haura-Pilot-TMT1-bRPLC02-2.raw": {
    "Source Name": [
      "20150820_Haura-Pilot-TMT1-bRPLC02-2"
    ],
    "Assay Name": [
      "20150820_Haura-Pilot-TMT1-bRPLC02-2.raw"
    ],
    "Raw Data File": [
      "20150820_Haura-Pilot-TMT1-bRPLC02-2.raw"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin digestion was carried out overnight at 37 \u00b0C"
    ],
    "Characteristics[ReductionReagent]": [
      "reduced with 4.5 mM DTT at 60 \u00b0C for 20 minutes"
    ],
    "Characteristics[AlkylationReagent]": [
      "alkylation with 11 mM iodoacetamide at room temperature for 15 minutes in the dark"
    ],
    "Characteristics[Label]": [
      "TMT 6-plex"
    ],
    "Characteristics[MaterialType]": [
      "Tissue samples were homogenized with a BioPulverizer (Biospec) and resuspended in lysis buffer containing 20 mM HEPES, pH 8.0, 9 M urea, 1 mM sodium orthovanadate, 2.5 mM sodium pyrophosphate, and 1 mM \u03b2-glycerophosphate."
    ],
    "Characteristics[NumberOfSamples]": [
      "4 frozen lung squamous cell carcinomas and 4 adjacent tissues"
    ],
    "Characteristics[Organism]": [
      "human entries in UniProt (downloaded 05/25/2015)"
    ],
    "Characteristics[SpikedCompound]": [
      "Twenty-five femtomoles of PRTC was spiked in each LC-MS/MS analysis to monitor instrument performance (Figure S1)."
    ],
    "Comment[Instrument]": [
      "QExactive Plus, Thermo, San Jose, CA"
    ],
    "Comment[FractionationMethod]": [
      "basic pH reversed phase HPLC"
    ],
    "Comment[NumberOfFractions]": [
      "Twelve concatenated fractions were analyzed with LC-MS/MS for the LF and TMT experiments."
    ],
    "Comment[AcquisitionMethod]": [
      "DDA"
    ],
    "Comment[CollisionEnergy]": [
      "the normalized collision energy value was set to 30."
    ],
    "Comment[Separation]": [
      "bRPLC separation"
    ],
    "Comment[GradientTime]": [
      "90-minute gradient"
    ],
    "Comment[FlowRateChromatogram]": [
      "The flow rate on analytical column was 300 nl/min."
    ],
    "Comment[FractionIdentifier]": [
      "bRPLC02"
    ]
  },
  "20150820_Haura-Pilot-TMT1-bRPLC05-2.raw": {
    "Source Name": [
      "20150820_Haura-Pilot-TMT1-bRPLC05-2"
    ],
    "Assay Name": [
      "20150820_Haura-Pilot-TMT1-bRPLC05-2.raw"
    ],
    "Raw Data File": [
      "20150820_Haura-Pilot-TMT1-bRPLC05-2.raw"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin digestion was carried out overnight at 37 \u00b0C"
    ],
    "Characteristics[ReductionReagent]": [
      "reduced with 4.5 mM DTT at 60 \u00b0C for 20 minutes"
    ],
    "Characteristics[AlkylationReagent]": [
      "alkylation with 11 mM iodoacetamide at room temperature for 15 minutes in the dark"
    ],
    "Characteristics[Label]": [
      "TMT 6-plex"
    ],
    "Characteristics[MaterialType]": [
      "Tissue samples were homogenized with a BioPulverizer (Biospec) and resuspended in lysis buffer containing 20 mM HEPES, pH 8.0, 9 M urea, 1 mM sodium orthovanadate, 2.5 mM sodium pyrophosphate, and 1 mM \u03b2-glycerophosphate."
    ],
    "Characteristics[NumberOfSamples]": [
      "4 frozen lung squamous cell carcinomas and 4 adjacent tissues"
    ],
    "Characteristics[Organism]": [
      "human entries in UniProt (downloaded 05/25/2015)"
    ],
    "Characteristics[SpikedCompound]": [
      "Twenty-five femtomoles of PRTC was spiked in each LC-MS/MS analysis to monitor instrument performance (Figure S1)."
    ],
    "Comment[Instrument]": [
      "QExactive Plus, Thermo, San Jose, CA"
    ],
    "Comment[FractionationMethod]": [
      "basic pH reversed phase HPLC"
    ],
    "Comment[NumberOfFractions]": [
      "Twelve concatenated fractions were analyzed with LC-MS/MS for the LF and TMT experiments."
    ],
    "Comment[AcquisitionMethod]": [
      "DDA"
    ],
    "Comment[CollisionEnergy]": [
      "the normalized collision energy value was set to 30."
    ],
    "Comment[Separation]": [
      "bRPLC separation"
    ],
    "Comment[GradientTime]": [
      "90-minute gradient"
    ],
    "Comment[FlowRateChromatogram]": [
      "The flow rate on analytical column was 300 nl/min."
    ],
    "Comment[FractionIdentifier]": [
      "bRPLC05"
    ]
  },
  "20150820_Haura-Pilot-TMT1-bRPLC02-1.raw": {
    "Source Name": [
      "20150820_Haura-Pilot-TMT1-bRPLC02-1"
    ],
    "Assay Name": [
      "20150820_Haura-Pilot-TMT1-bRPLC02-1.raw"
    ],
    "Raw Data File": [
      "20150820_Haura-Pilot-TMT1-bRPLC02-1.raw"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin digestion was carried out overnight at 37 \u00b0C"
    ],
    "Characteristics[ReductionReagent]": [
      "reduced with 4.5 mM DTT at 60 \u00b0C for 20 minutes"
    ],
    "Characteristics[AlkylationReagent]": [
      "alkylation with 11 mM iodoacetamide at room temperature for 15 minutes in the dark"
    ],
    "Characteristics[Label]": [
      "TMT 6-plex"
    ],
    "Characteristics[MaterialType]": [
      "Tissue samples were homogenized with a BioPulverizer (Biospec) and resuspended in lysis buffer containing 20 mM HEPES, pH 8.0, 9 M urea, 1 mM sodium orthovanadate, 2.5 mM sodium pyrophosphate, and 1 mM \u03b2-glycerophosphate."
    ],
    "Characteristics[NumberOfSamples]": [
      "4 frozen lung squamous cell carcinomas and 4 adjacent tissues"
    ],
    "Characteristics[Organism]": [
      "human entries in UniProt (downloaded 05/25/2015)"
    ],
    "Characteristics[SpikedCompound]": [
      "Twenty-five femtomoles of PRTC was spiked in each LC-MS/MS analysis to monitor instrument performance (Figure S1)."
    ],
    "Comment[Instrument]": [
      "QExactive Plus, Thermo, San Jose, CA"
    ],
    "Comment[FractionationMethod]": [
      "basic pH reversed phase HPLC"
    ],
    "Comment[NumberOfFractions]": [
      "Twelve concatenated fractions were analyzed with LC-MS/MS for the LF and TMT experiments."
    ],
    "Comment[AcquisitionMethod]": [
      "DDA"
    ],
    "Comment[CollisionEnergy]": [
      "the normalized collision energy value was set to 30."
    ],
    "Comment[Separation]": [
      "bRPLC separation"
    ],
    "Comment[GradientTime]": [
      "90-minute gradient"
    ],
    "Comment[FlowRateChromatogram]": [
      "The flow rate on analytical column was 300 nl/min."
    ],
    "Comment[FractionIdentifier]": [
      "bRPLC02"
    ]
  },
  "20150820_Haura-Pilot-TMT2-bRPLC07-2.raw": {
    "Source Name": [
      "20150820_Haura-Pilot-TMT2-bRPLC07-2"
    ],
    "Assay Name": [
      "20150820_Haura-Pilot-TMT2-bRPLC07-2.raw"
    ],
    "Raw Data File": [
      "20150820_Haura-Pilot-TMT2-bRPLC07-2.raw"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin digestion was carried out overnight at 37 \u00b0C"
    ],
    "Characteristics[ReductionReagent]": [
      "reduced with 4.5 mM DTT at 60 \u00b0C for 20 minutes"
    ],
    "Characteristics[AlkylationReagent]": [
      "alkylation with 11 mM iodoacetamide at room temperature for 15 minutes in the dark"
    ],
    "Characteristics[Label]": [
      "TMT 6-plex"
    ],
    "Characteristics[MaterialType]": [
      "Tissue samples were homogenized with a BioPulverizer (Biospec) and resuspended in lysis buffer containing 20 mM HEPES, pH 8.0, 9 M urea, 1 mM sodium orthovanadate, 2.5 mM sodium pyrophosphate, and 1 mM \u03b2-glycerophosphate."
    ],
    "Characteristics[NumberOfSamples]": [
      "4 frozen lung squamous cell carcinomas and 4 adjacent tissues"
    ],
    "Characteristics[Organism]": [
      "human entries in UniProt (downloaded 05/25/2015)"
    ],
    "Characteristics[SpikedCompound]": [
      "Twenty-five femtomoles of PRTC was spiked in each LC-MS/MS analysis to monitor instrument performance (Figure S1)."
    ],
    "Comment[Instrument]": [
      "QExactive Plus, Thermo, San Jose, CA"
    ],
    "Comment[FractionationMethod]": [
      "basic pH reversed phase HPLC"
    ],
    "Comment[NumberOfFractions]": [
      "Twelve concatenated fractions were analyzed with LC-MS/MS for the LF and TMT experiments."
    ],
    "Comment[AcquisitionMethod]": [
      "DDA"
    ],
    "Comment[CollisionEnergy]": [
      "the normalized collision energy value was set to 30."
    ],
    "Comment[Separation]": [
      "bRPLC separation"
    ],
    "Comment[GradientTime]": [
      "90-minute gradient"
    ],
    "Comment[FlowRateChromatogram]": [
      "The flow rate on analytical column was 300 nl/min."
    ],
    "Comment[FractionIdentifier]": [
      "bRPLC07"
    ]
  },
  "20150820_Haura-Pilot-TMT1-bRPLC08-1.raw": {
    "Source Name": [
      "20150820_Haura-Pilot-TMT1-bRPLC08-1"
    ],
    "Assay Name": [
      "20150820_Haura-Pilot-TMT1-bRPLC08-1.raw"
    ],
    "Raw Data File": [
      "20150820_Haura-Pilot-TMT1-bRPLC08-1.raw"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin digestion was carried out overnight at 37 \u00b0C"
    ],
    "Characteristics[ReductionReagent]": [
      "reduced with 4.5 mM DTT at 60 \u00b0C for 20 minutes"
    ],
    "Characteristics[AlkylationReagent]": [
      "alkylation with 11 mM iodoacetamide at room temperature for 15 minutes in the dark"
    ],
    "Characteristics[Label]": [
      "TMT 6-plex"
    ],
    "Characteristics[MaterialType]": [
      "Tissue samples were homogenized with a BioPulverizer (Biospec) and resuspended in lysis buffer containing 20 mM HEPES, pH 8.0, 9 M urea, 1 mM sodium orthovanadate, 2.5 mM sodium pyrophosphate, and 1 mM \u03b2-glycerophosphate."
    ],
    "Characteristics[NumberOfSamples]": [
      "4 frozen lung squamous cell carcinomas and 4 adjacent tissues"
    ],
    "Characteristics[Organism]": [
      "human entries in UniProt (downloaded 05/25/2015)"
    ],
    "Characteristics[SpikedCompound]": [
      "Twenty-five femtomoles of PRTC was spiked in each LC-MS/MS analysis to monitor instrument performance (Figure S1)."
    ],
    "Comment[Instrument]": [
      "QExactive Plus, Thermo, San Jose, CA"
    ],
    "Comment[FractionationMethod]": [
      "basic pH reversed phase HPLC"
    ],
    "Comment[NumberOfFractions]": [
      "Twelve concatenated fractions were analyzed with LC-MS/MS for the LF and TMT experiments."
    ],
    "Comment[AcquisitionMethod]": [
      "DDA"
    ],
    "Comment[CollisionEnergy]": [
      "the normalized collision energy value was set to 30."
    ],
    "Comment[Separation]": [
      "bRPLC separation"
    ],
    "Comment[GradientTime]": [
      "90-minute gradient"
    ],
    "Comment[FlowRateChromatogram]": [
      "The flow rate on analytical column was 300 nl/min."
    ],
    "Comment[FractionIdentifier]": [
      "bRPLC08"
    ]
  },
  "20150820_Haura-Pilot-TMT1-bRPLC06-2.raw": {
    "Source Name": [
      "20150820_Haura-Pilot-TMT1-bRPLC06-2"
    ],
    "Assay Name": [
      "20150820_Haura-Pilot-TMT1-bRPLC06-2.raw"
    ],
    "Raw Data File": [
      "20150820_Haura-Pilot-TMT1-bRPLC06-2.raw"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin digestion was carried out overnight at 37 \u00b0C"
    ],
    "Characteristics[ReductionReagent]": [
      "reduced with 4.5 mM DTT at 60 \u00b0C for 20 minutes"
    ],
    "Characteristics[AlkylationReagent]": [
      "alkylation with 11 mM iodoacetamide at room temperature for 15 minutes in the dark"
    ],
    "Characteristics[Label]": [
      "TMT 6-plex"
    ],
    "Characteristics[MaterialType]": [
      "Tissue samples were homogenized with a BioPulverizer (Biospec) and resuspended in lysis buffer containing 20 mM HEPES, pH 8.0, 9 M urea, 1 mM sodium orthovanadate, 2.5 mM sodium pyrophosphate, and 1 mM \u03b2-glycerophosphate."
    ],
    "Characteristics[NumberOfSamples]": [
      "4 frozen lung squamous cell carcinomas and 4 adjacent tissues"
    ],
    "Characteristics[Organism]": [
      "human entries in UniProt (downloaded 05/25/2015)"
    ],
    "Characteristics[SpikedCompound]": [
      "Twenty-five femtomoles of PRTC was spiked in each LC-MS/MS analysis to monitor instrument performance (Figure S1)."
    ],
    "Comment[Instrument]": [
      "QExactive Plus, Thermo, San Jose, CA"
    ],
    "Comment[FractionationMethod]": [
      "basic pH reversed phase HPLC"
    ],
    "Comment[NumberOfFractions]": [
      "Twelve concatenated fractions were analyzed with LC-MS/MS for the LF and TMT experiments."
    ],
    "Comment[AcquisitionMethod]": [
      "DDA"
    ],
    "Comment[CollisionEnergy]": [
      "the normalized collision energy value was set to 30."
    ],
    "Comment[Separation]": [
      "bRPLC separation"
    ],
    "Comment[GradientTime]": [
      "90-minute gradient"
    ],
    "Comment[FlowRateChromatogram]": [
      "The flow rate on analytical column was 300 nl/min."
    ],
    "Comment[FractionIdentifier]": [
      "bRPLC06"
    ]
  },
  "20150820_Haura-Pilot-TMT2-bRPLC03-2.raw": {
    "Source Name": [
      "20150820_Haura-Pilot-TMT2-bRPLC03-2"
    ],
    "Assay Name": [
      "20150820_Haura-Pilot-TMT2-bRPLC03-2.raw"
    ],
    "Raw Data File": [
      "20150820_Haura-Pilot-TMT2-bRPLC03-2.raw"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin digestion was carried out overnight at 37 \u00b0C"
    ],
    "Characteristics[ReductionReagent]": [
      "reduced with 4.5 mM DTT at 60 \u00b0C for 20 minutes"
    ],
    "Characteristics[AlkylationReagent]": [
      "alkylation with 11 mM iodoacetamide at room temperature for 15 minutes in the dark"
    ],
    "Characteristics[Label]": [
      "TMT 6-plex"
    ],
    "Characteristics[MaterialType]": [
      "Tissue samples were homogenized with a BioPulverizer (Biospec) and resuspended in lysis buffer containing 20 mM HEPES, pH 8.0, 9 M urea, 1 mM sodium orthovanadate, 2.5 mM sodium pyrophosphate, and 1 mM \u03b2-glycerophosphate."
    ],
    "Characteristics[NumberOfSamples]": [
      "4 frozen lung squamous cell carcinomas and 4 adjacent tissues"
    ],
    "Characteristics[Organism]": [
      "human entries in UniProt (downloaded 05/25/2015)"
    ],
    "Characteristics[SpikedCompound]": [
      "Twenty-five femtomoles of PRTC was spiked in each LC-MS/MS analysis to monitor instrument performance (Figure S1)."
    ],
    "Comment[Instrument]": [
      "QExactive Plus, Thermo, San Jose, CA"
    ],
    "Comment[FractionationMethod]": [
      "basic pH reversed phase HPLC"
    ],
    "Comment[NumberOfFractions]": [
      "Twelve concatenated fractions were analyzed with LC-MS/MS for the LF and TMT experiments."
    ],
    "Comment[AcquisitionMethod]": [
      "DDA"
    ],
    "Comment[CollisionEnergy]": [
      "the normalized collision energy value was set to 30."
    ],
    "Comment[Separation]": [
      "bRPLC separation"
    ],
    "Comment[GradientTime]": [
      "90-minute gradient"
    ],
    "Comment[FlowRateChromatogram]": [
      "The flow rate on analytical column was 300 nl/min."
    ],
    "Comment[FractionIdentifier]": [
      "bRPLC03"
    ]
  },
  "20150820_Haura-Pilot-TMT1-bRPLC10-2.raw": {
    "Source Name": [
      "20150820_Haura-Pilot-TMT1-bRPLC10-2"
    ],
    "Assay Name": [
      "20150820_Haura-Pilot-TMT1-bRPLC10-2.raw"
    ],
    "Raw Data File": [
      "20150820_Haura-Pilot-TMT1-bRPLC10-2.raw"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin digestion was carried out overnight at 37 \u00b0C"
    ],
    "Characteristics[ReductionReagent]": [
      "reduced with 4.5 mM DTT at 60 \u00b0C for 20 minutes"
    ],
    "Characteristics[AlkylationReagent]": [
      "alkylation with 11 mM iodoacetamide at room temperature for 15 minutes in the dark"
    ],
    "Characteristics[Label]": [
      "TMT 6-plex"
    ],
    "Characteristics[MaterialType]": [
      "Tissue samples were homogenized with a BioPulverizer (Biospec) and resuspended in lysis buffer containing 20 mM HEPES, pH 8.0, 9 M urea, 1 mM sodium orthovanadate, 2.5 mM sodium pyrophosphate, and 1 mM \u03b2-glycerophosphate."
    ],
    "Characteristics[NumberOfSamples]": [
      "4 frozen lung squamous cell carcinomas and 4 adjacent tissues"
    ],
    "Characteristics[Organism]": [
      "human entries in UniProt (downloaded 05/25/2015)"
    ],
    "Characteristics[SpikedCompound]": [
      "Twenty-five femtomoles of PRTC was spiked in each LC-MS/MS analysis to monitor instrument performance (Figure S1)."
    ],
    "Comment[Instrument]": [
      "QExactive Plus, Thermo, San Jose, CA"
    ],
    "Comment[FractionationMethod]": [
      "basic pH reversed phase HPLC"
    ],
    "Comment[NumberOfFractions]": [
      "Twelve concatenated fractions were analyzed with LC-MS/MS for the LF and TMT experiments."
    ],
    "Comment[AcquisitionMethod]": [
      "DDA"
    ],
    "Comment[CollisionEnergy]": [
      "the normalized collision energy value was set to 30."
    ],
    "Comment[Separation]": [
      "bRPLC separation"
    ],
    "Comment[GradientTime]": [
      "90-minute gradient"
    ],
    "Comment[FlowRateChromatogram]": [
      "The flow rate on analytical column was 300 nl/min."
    ],
    "Comment[FractionIdentifier]": [
      "bRPLC10"
    ]
  },
  "20150820_Haura-Pilot-TMT2-bRPLC09-1.raw": {
    "Source Name": [
      "20150820_Haura-Pilot-TMT2-bRPLC09-1"
    ],
    "Assay Name": [
      "20150820_Haura-Pilot-TMT2-bRPLC09-1.raw"
    ],
    "Raw Data File": [
      "20150820_Haura-Pilot-TMT2-bRPLC09-1.raw"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin digestion was carried out overnight at 37 \u00b0C"
    ],
    "Characteristics[ReductionReagent]": [
      "reduced with 4.5 mM DTT at 60 \u00b0C for 20 minutes"
    ],
    "Characteristics[AlkylationReagent]": [
      "alkylation with 11 mM iodoacetamide at room temperature for 15 minutes in the dark"
    ],
    "Characteristics[Label]": [
      "TMT 6-plex"
    ],
    "Characteristics[MaterialType]": [
      "Tissue samples were homogenized with a BioPulverizer (Biospec) and resuspended in lysis buffer containing 20 mM HEPES, pH 8.0, 9 M urea, 1 mM sodium orthovanadate, 2.5 mM sodium pyrophosphate, and 1 mM \u03b2-glycerophosphate."
    ],
    "Characteristics[NumberOfSamples]": [
      "4 frozen lung squamous cell carcinomas and 4 adjacent tissues"
    ],
    "Characteristics[Organism]": [
      "human entries in UniProt (downloaded 05/25/2015)"
    ],
    "Characteristics[SpikedCompound]": [
      "Twenty-five femtomoles of PRTC was spiked in each LC-MS/MS analysis to monitor instrument performance (Figure S1)."
    ],
    "Comment[Instrument]": [
      "QExactive Plus, Thermo, San Jose, CA"
    ],
    "Comment[FractionationMethod]": [
      "basic pH reversed phase HPLC"
    ],
    "Comment[NumberOfFractions]": [
      "Twelve concatenated fractions were analyzed with LC-MS/MS for the LF and TMT experiments."
    ],
    "Comment[AcquisitionMethod]": [
      "DDA"
    ],
    "Comment[CollisionEnergy]": [
      "the normalized collision energy value was set to 30."
    ],
    "Comment[Separation]": [
      "bRPLC separation"
    ],
    "Comment[GradientTime]": [
      "90-minute gradient"
    ],
    "Comment[FlowRateChromatogram]": [
      "The flow rate on analytical column was 300 nl/min."
    ],
    "Comment[FractionIdentifier]": [
      "bRPLC09"
    ]
  },
  "20150820_Haura-Pilot-TMT1-bRPLC09-2.raw": {
    "Source Name": [
      "20150820_Haura-Pilot-TMT1-bRPLC09-2"
    ],
    "Assay Name": [
      "20150820_Haura-Pilot-TMT1-bRPLC09-2.raw"
    ],
    "Raw Data File": [
      "20150820_Haura-Pilot-TMT1-bRPLC09-2.raw"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin digestion was carried out overnight at 37 \u00b0C"
    ],
    "Characteristics[ReductionReagent]": [
      "reduced with 4.5 mM DTT at 60 \u00b0C for 20 minutes"
    ],
    "Characteristics[AlkylationReagent]": [
      "alkylation with 11 mM iodoacetamide at room temperature for 15 minutes in the dark"
    ],
    "Characteristics[Label]": [
      "TMT 6-plex"
    ],
    "Characteristics[MaterialType]": [
      "Tissue samples were homogenized with a BioPulverizer (Biospec) and resuspended in lysis buffer containing 20 mM HEPES, pH 8.0, 9 M urea, 1 mM sodium orthovanadate, 2.5 mM sodium pyrophosphate, and 1 mM \u03b2-glycerophosphate."
    ],
    "Characteristics[NumberOfSamples]": [
      "4 frozen lung squamous cell carcinomas and 4 adjacent tissues"
    ],
    "Characteristics[Organism]": [
      "human entries in UniProt (downloaded 05/25/2015)"
    ],
    "Characteristics[SpikedCompound]": [
      "Twenty-five femtomoles of PRTC was spiked in each LC-MS/MS analysis to monitor instrument performance (Figure S1)."
    ],
    "Comment[Instrument]": [
      "QExactive Plus, Thermo, San Jose, CA"
    ],
    "Comment[FractionationMethod]": [
      "basic pH reversed phase HPLC"
    ],
    "Comment[NumberOfFractions]": [
      "Twelve concatenated fractions were analyzed with LC-MS/MS for the LF and TMT experiments."
    ],
    "Comment[AcquisitionMethod]": [
      "DDA"
    ],
    "Comment[CollisionEnergy]": [
      "the normalized collision energy value was set to 30."
    ],
    "Comment[Separation]": [
      "bRPLC separation"
    ],
    "Comment[GradientTime]": [
      "90-minute gradient"
    ],
    "Comment[FlowRateChromatogram]": [
      "The flow rate on analytical column was 300 nl/min."
    ],
    "Comment[FractionIdentifier]": [
      "bRPLC09"
    ]
  },
  "20150820_Haura-Pilot-TMT2-bRPLC03-1.raw": {
    "Source Name": [
      "20150820_Haura-Pilot-TMT2-bRPLC03-1"
    ],
    "Assay Name": [
      "20150820_Haura-Pilot-TMT2-bRPLC03-1.raw"
    ],
    "Raw Data File": [
      "20150820_Haura-Pilot-TMT2-bRPLC03-1.raw"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin digestion was carried out overnight at 37 \u00b0C"
    ],
    "Characteristics[ReductionReagent]": [
      "reduced with 4.5 mM DTT at 60 \u00b0C for 20 minutes"
    ],
    "Characteristics[AlkylationReagent]": [
      "alkylation with 11 mM iodoacetamide at room temperature for 15 minutes in the dark"
    ],
    "Characteristics[Label]": [
      "TMT 6-plex"
    ],
    "Characteristics[MaterialType]": [
      "Tissue samples were homogenized with a BioPulverizer (Biospec) and resuspended in lysis buffer containing 20 mM HEPES, pH 8.0, 9 M urea, 1 mM sodium orthovanadate, 2.5 mM sodium pyrophosphate, and 1 mM \u03b2-glycerophosphate."
    ],
    "Characteristics[NumberOfSamples]": [
      "4 frozen lung squamous cell carcinomas and 4 adjacent tissues"
    ],
    "Characteristics[Organism]": [
      "human entries in UniProt (downloaded 05/25/2015)"
    ],
    "Characteristics[SpikedCompound]": [
      "Twenty-five femtomoles of PRTC was spiked in each LC-MS/MS analysis to monitor instrument performance (Figure S1)."
    ],
    "Comment[Instrument]": [
      "QExactive Plus, Thermo, San Jose, CA"
    ],
    "Comment[FractionationMethod]": [
      "basic pH reversed phase HPLC"
    ],
    "Comment[NumberOfFractions]": [
      "Twelve concatenated fractions were analyzed with LC-MS/MS for the LF and TMT experiments."
    ],
    "Comment[AcquisitionMethod]": [
      "DDA"
    ],
    "Comment[CollisionEnergy]": [
      "the normalized collision energy value was set to 30."
    ],
    "Comment[Separation]": [
      "bRPLC separation"
    ],
    "Comment[GradientTime]": [
      "90-minute gradient"
    ],
    "Comment[FlowRateChromatogram]": [
      "The flow rate on analytical column was 300 nl/min."
    ],
    "Comment[FractionIdentifier]": [
      "bRPLC03"
    ]
  },
  "20150820_Haura-Pilot-TMT2-bRPLC07-1.raw": {
    "Source Name": [
      "20150820_Haura-Pilot-TMT2-bRPLC07-1"
    ],
    "Assay Name": [
      "20150820_Haura-Pilot-TMT2-bRPLC07-1.raw"
    ],
    "Raw Data File": [
      "20150820_Haura-Pilot-TMT2-bRPLC07-1.raw"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin digestion was carried out overnight at 37 \u00b0C"
    ],
    "Characteristics[ReductionReagent]": [
      "reduced with 4.5 mM DTT at 60 \u00b0C for 20 minutes"
    ],
    "Characteristics[AlkylationReagent]": [
      "alkylation with 11 mM iodoacetamide at room temperature for 15 minutes in the dark"
    ],
    "Characteristics[Label]": [
      "TMT 6-plex"
    ],
    "Characteristics[MaterialType]": [
      "Tissue samples were homogenized with a BioPulverizer (Biospec) and resuspended in lysis buffer containing 20 mM HEPES, pH 8.0, 9 M urea, 1 mM sodium orthovanadate, 2.5 mM sodium pyrophosphate, and 1 mM \u03b2-glycerophosphate."
    ],
    "Characteristics[NumberOfSamples]": [
      "4 frozen lung squamous cell carcinomas and 4 adjacent tissues"
    ],
    "Characteristics[Organism]": [
      "human entries in UniProt (downloaded 05/25/2015)"
    ],
    "Characteristics[SpikedCompound]": [
      "Twenty-five femtomoles of PRTC was spiked in each LC-MS/MS analysis to monitor instrument performance (Figure S1)."
    ],
    "Comment[Instrument]": [
      "QExactive Plus, Thermo, San Jose, CA"
    ],
    "Comment[FractionationMethod]": [
      "basic pH reversed phase HPLC"
    ],
    "Comment[NumberOfFractions]": [
      "Twelve concatenated fractions were analyzed with LC-MS/MS for the LF and TMT experiments."
    ],
    "Comment[AcquisitionMethod]": [
      "DDA"
    ],
    "Comment[CollisionEnergy]": [
      "the normalized collision energy value was set to 30."
    ],
    "Comment[Separation]": [
      "bRPLC separation"
    ],
    "Comment[GradientTime]": [
      "90-minute gradient"
    ],
    "Comment[FlowRateChromatogram]": [
      "The flow rate on analytical column was 300 nl/min."
    ],
    "Comment[FractionIdentifier]": [
      "bRPLC07"
    ]
  },
  "20150820_Haura-Pilot-TMT2-bRPLC01-1.raw": {
    "Source Name": [
      "20150820_Haura-Pilot-TMT2-bRPLC01-1"
    ],
    "Assay Name": [
      "20150820_Haura-Pilot-TMT2-bRPLC01-1.raw"
    ],
    "Raw Data File": [
      "20150820_Haura-Pilot-TMT2-bRPLC01-1.raw"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin digestion was carried out overnight at 37 \u00b0C"
    ],
    "Characteristics[ReductionReagent]": [
      "reduced with 4.5 mM DTT at 60 \u00b0C for 20 minutes"
    ],
    "Characteristics[AlkylationReagent]": [
      "alkylation with 11 mM iodoacetamide at room temperature for 15 minutes in the dark"
    ],
    "Characteristics[Label]": [
      "TMT 6-plex"
    ],
    "Characteristics[MaterialType]": [
      "Tissue samples were homogenized with a BioPulverizer (Biospec) and resuspended in lysis buffer containing 20 mM HEPES, pH 8.0, 9 M urea, 1 mM sodium orthovanadate, 2.5 mM sodium pyrophosphate, and 1 mM \u03b2-glycerophosphate."
    ],
    "Characteristics[NumberOfSamples]": [
      "4 frozen lung squamous cell carcinomas and 4 adjacent tissues"
    ],
    "Characteristics[Organism]": [
      "human entries in UniProt (downloaded 05/25/2015)"
    ],
    "Characteristics[SpikedCompound]": [
      "Twenty-five femtomoles of PRTC was spiked in each LC-MS/MS analysis to monitor instrument performance (Figure S1)."
    ],
    "Comment[Instrument]": [
      "QExactive Plus, Thermo, San Jose, CA"
    ],
    "Comment[FractionationMethod]": [
      "basic pH reversed phase HPLC"
    ],
    "Comment[NumberOfFractions]": [
      "Twelve concatenated fractions were analyzed with LC-MS/MS for the LF and TMT experiments."
    ],
    "Comment[AcquisitionMethod]": [
      "DDA"
    ],
    "Comment[CollisionEnergy]": [
      "the normalized collision energy value was set to 30."
    ],
    "Comment[Separation]": [
      "bRPLC separation"
    ],
    "Comment[GradientTime]": [
      "90-minute gradient"
    ],
    "Comment[FlowRateChromatogram]": [
      "The flow rate on analytical column was 300 nl/min."
    ],
    "Comment[FractionIdentifier]": [
      "bRPLC01"
    ]
  },
  "20150820_Haura-Pilot-TMT1-bRPLC03-1.raw": {
    "Source Name": [
      "20150820_Haura-Pilot-TMT1-bRPLC03-1"
    ],
    "Assay Name": [
      "20150820_Haura-Pilot-TMT1-bRPLC03-1.raw"
    ],
    "Raw Data File": [
      "20150820_Haura-Pilot-TMT1-bRPLC03-1.raw"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin digestion was carried out overnight at 37 \u00b0C"
    ],
    "Characteristics[ReductionReagent]": [
      "reduced with 4.5 mM DTT at 60 \u00b0C for 20 minutes"
    ],
    "Characteristics[AlkylationReagent]": [
      "alkylation with 11 mM iodoacetamide at room temperature for 15 minutes in the dark"
    ],
    "Characteristics[Label]": [
      "TMT 6-plex"
    ],
    "Characteristics[MaterialType]": [
      "Tissue samples were homogenized with a BioPulverizer (Biospec) and resuspended in lysis buffer containing 20 mM HEPES, pH 8.0, 9 M urea, 1 mM sodium orthovanadate, 2.5 mM sodium pyrophosphate, and 1 mM \u03b2-glycerophosphate."
    ],
    "Characteristics[NumberOfSamples]": [
      "4 frozen lung squamous cell carcinomas and 4 adjacent tissues"
    ],
    "Characteristics[Organism]": [
      "human entries in UniProt (downloaded 05/25/2015)"
    ],
    "Characteristics[SpikedCompound]": [
      "Twenty-five femtomoles of PRTC was spiked in each LC-MS/MS analysis to monitor instrument performance (Figure S1)."
    ],
    "Comment[Instrument]": [
      "QExactive Plus, Thermo, San Jose, CA"
    ],
    "Comment[FractionationMethod]": [
      "basic pH reversed phase HPLC"
    ],
    "Comment[NumberOfFractions]": [
      "Twelve concatenated fractions were analyzed with LC-MS/MS for the LF and TMT experiments."
    ],
    "Comment[AcquisitionMethod]": [
      "DDA"
    ],
    "Comment[CollisionEnergy]": [
      "the normalized collision energy value was set to 30."
    ],
    "Comment[Separation]": [
      "bRPLC separation"
    ],
    "Comment[GradientTime]": [
      "90-minute gradient"
    ],
    "Comment[FlowRateChromatogram]": [
      "The flow rate on analytical column was 300 nl/min."
    ],
    "Comment[FractionIdentifier]": [
      "bRPLC03"
    ]
  },
  "20150820_Haura-Pilot-TMT2-bRPLC01-2.raw": {
    "Source Name": [
      "20150820_Haura-Pilot-TMT2-bRPLC01-2"
    ],
    "Assay Name": [
      "20150820_Haura-Pilot-TMT2-bRPLC01-2.raw"
    ],
    "Raw Data File": [
      "20150820_Haura-Pilot-TMT2-bRPLC01-2.raw"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin digestion was carried out overnight at 37 \u00b0C"
    ],
    "Characteristics[ReductionReagent]": [
      "reduced with 4.5 mM DTT at 60 \u00b0C for 20 minutes"
    ],
    "Characteristics[AlkylationReagent]": [
      "alkylation with 11 mM iodoacetamide at room temperature for 15 minutes in the dark"
    ],
    "Characteristics[Label]": [
      "TMT 6-plex"
    ],
    "Characteristics[MaterialType]": [
      "Tissue samples were homogenized with a BioPulverizer (Biospec) and resuspended in lysis buffer containing 20 mM HEPES, pH 8.0, 9 M urea, 1 mM sodium orthovanadate, 2.5 mM sodium pyrophosphate, and 1 mM \u03b2-glycerophosphate."
    ],
    "Characteristics[NumberOfSamples]": [
      "4 frozen lung squamous cell carcinomas and 4 adjacent tissues"
    ],
    "Characteristics[Organism]": [
      "human entries in UniProt (downloaded 05/25/2015)"
    ],
    "Characteristics[SpikedCompound]": [
      "Twenty-five femtomoles of PRTC was spiked in each LC-MS/MS analysis to monitor instrument performance (Figure S1)."
    ],
    "Comment[Instrument]": [
      "QExactive Plus, Thermo, San Jose, CA"
    ],
    "Comment[FractionationMethod]": [
      "basic pH reversed phase HPLC"
    ],
    "Comment[NumberOfFractions]": [
      "Twelve concatenated fractions were analyzed with LC-MS/MS for the LF and TMT experiments."
    ],
    "Comment[AcquisitionMethod]": [
      "DDA"
    ],
    "Comment[CollisionEnergy]": [
      "the normalized collision energy value was set to 30."
    ],
    "Comment[Separation]": [
      "bRPLC separation"
    ],
    "Comment[GradientTime]": [
      "90-minute gradient"
    ],
    "Comment[FlowRateChromatogram]": [
      "The flow rate on analytical column was 300 nl/min."
    ],
    "Comment[FractionIdentifier]": [
      "bRPLC01"
    ]
  },
  "20150820_Haura-Pilot-TMT1-bRPLC08-2.raw": {
    "Source Name": [
      "20150820_Haura-Pilot-TMT1-bRPLC08-2"
    ],
    "Assay Name": [
      "20150820_Haura-Pilot-TMT1-bRPLC08-2.raw"
    ],
    "Raw Data File": [
      "20150820_Haura-Pilot-TMT1-bRPLC08-2.raw"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin digestion was carried out overnight at 37 \u00b0C"
    ],
    "Characteristics[ReductionReagent]": [
      "reduced with 4.5 mM DTT at 60 \u00b0C for 20 minutes"
    ],
    "Characteristics[AlkylationReagent]": [
      "alkylation with 11 mM iodoacetamide at room temperature for 15 minutes in the dark"
    ],
    "Characteristics[Label]": [
      "TMT 6-plex"
    ],
    "Characteristics[MaterialType]": [
      "Tissue samples were homogenized with a BioPulverizer (Biospec) and resuspended in lysis buffer containing 20 mM HEPES, pH 8.0, 9 M urea, 1 mM sodium orthovanadate, 2.5 mM sodium pyrophosphate, and 1 mM \u03b2-glycerophosphate."
    ],
    "Characteristics[NumberOfSamples]": [
      "4 frozen lung squamous cell carcinomas and 4 adjacent tissues"
    ],
    "Characteristics[Organism]": [
      "human entries in UniProt (downloaded 05/25/2015)"
    ],
    "Characteristics[SpikedCompound]": [
      "Twenty-five femtomoles of PRTC was spiked in each LC-MS/MS analysis to monitor instrument performance (Figure S1)."
    ],
    "Comment[Instrument]": [
      "QExactive Plus, Thermo, San Jose, CA"
    ],
    "Comment[FractionationMethod]": [
      "basic pH reversed phase HPLC"
    ],
    "Comment[NumberOfFractions]": [
      "Twelve concatenated fractions were analyzed with LC-MS/MS for the LF and TMT experiments."
    ],
    "Comment[AcquisitionMethod]": [
      "DDA"
    ],
    "Comment[CollisionEnergy]": [
      "the normalized collision energy value was set to 30."
    ],
    "Comment[Separation]": [
      "bRPLC separation"
    ],
    "Comment[GradientTime]": [
      "90-minute gradient"
    ],
    "Comment[FlowRateChromatogram]": [
      "The flow rate on analytical column was 300 nl/min."
    ],
    "Comment[FractionIdentifier]": [
      "bRPLC08"
    ]
  },
  "20150820_Haura-Pilot-TMT2-bRPLC12-2.raw": {
    "Source Name": [
      "20150820_Haura-Pilot-TMT2-bRPLC12-2"
    ],
    "Assay Name": [
      "20150820_Haura-Pilot-TMT2-bRPLC12-2.raw"
    ],
    "Raw Data File": [
      "20150820_Haura-Pilot-TMT2-bRPLC12-2.raw"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin digestion was carried out overnight at 37 \u00b0C"
    ],
    "Characteristics[ReductionReagent]": [
      "reduced with 4.5 mM DTT at 60 \u00b0C for 20 minutes"
    ],
    "Characteristics[AlkylationReagent]": [
      "alkylation with 11 mM iodoacetamide at room temperature for 15 minutes in the dark"
    ],
    "Characteristics[Label]": [
      "TMT 6-plex"
    ],
    "Characteristics[MaterialType]": [
      "Tissue samples were homogenized with a BioPulverizer (Biospec) and resuspended in lysis buffer containing 20 mM HEPES, pH 8.0, 9 M urea, 1 mM sodium orthovanadate, 2.5 mM sodium pyrophosphate, and 1 mM \u03b2-glycerophosphate."
    ],
    "Characteristics[NumberOfSamples]": [
      "4 frozen lung squamous cell carcinomas and 4 adjacent tissues"
    ],
    "Characteristics[Organism]": [
      "human entries in UniProt (downloaded 05/25/2015)"
    ],
    "Characteristics[SpikedCompound]": [
      "Twenty-five femtomoles of PRTC was spiked in each LC-MS/MS analysis to monitor instrument performance (Figure S1)."
    ],
    "Comment[Instrument]": [
      "QExactive Plus, Thermo, San Jose, CA"
    ],
    "Comment[FractionationMethod]": [
      "basic pH reversed phase HPLC"
    ],
    "Comment[NumberOfFractions]": [
      "Twelve concatenated fractions were analyzed with LC-MS/MS for the LF and TMT experiments."
    ],
    "Comment[AcquisitionMethod]": [
      "DDA"
    ],
    "Comment[CollisionEnergy]": [
      "the normalized collision energy value was set to 30."
    ],
    "Comment[Separation]": [
      "bRPLC separation"
    ],
    "Comment[GradientTime]": [
      "90-minute gradient"
    ],
    "Comment[FlowRateChromatogram]": [
      "The flow rate on analytical column was 300 nl/min."
    ],
    "Comment[FractionIdentifier]": [
      "bRPLC12"
    ]
  },
  "20150820_Haura-Pilot-TMT2-bRPLC12-1.raw": {
    "Source Name": [
      "20150820_Haura-Pilot-TMT2-bRPLC12-1"
    ],
    "Assay Name": [
      "20150820_Haura-Pilot-TMT2-bRPLC12-1.raw"
    ],
    "Raw Data File": [
      "20150820_Haura-Pilot-TMT2-bRPLC12-1.raw"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin digestion was carried out overnight at 37 \u00b0C"
    ],
    "Characteristics[ReductionReagent]": [
      "reduced with 4.5 mM DTT at 60 \u00b0C for 20 minutes"
    ],
    "Characteristics[AlkylationReagent]": [
      "alkylation with 11 mM iodoacetamide at room temperature for 15 minutes in the dark"
    ],
    "Characteristics[Label]": [
      "TMT 6-plex"
    ],
    "Characteristics[MaterialType]": [
      "Tissue samples were homogenized with a BioPulverizer (Biospec) and resuspended in lysis buffer containing 20 mM HEPES, pH 8.0, 9 M urea, 1 mM sodium orthovanadate, 2.5 mM sodium pyrophosphate, and 1 mM \u03b2-glycerophosphate."
    ],
    "Characteristics[NumberOfSamples]": [
      "4 frozen lung squamous cell carcinomas and 4 adjacent tissues"
    ],
    "Characteristics[Organism]": [
      "human entries in UniProt (downloaded 05/25/2015)"
    ],
    "Characteristics[SpikedCompound]": [
      "Twenty-five femtomoles of PRTC was spiked in each LC-MS/MS analysis to monitor instrument performance (Figure S1)."
    ],
    "Comment[Instrument]": [
      "QExactive Plus, Thermo, San Jose, CA"
    ],
    "Comment[FractionationMethod]": [
      "basic pH reversed phase HPLC"
    ],
    "Comment[NumberOfFractions]": [
      "Twelve concatenated fractions were analyzed with LC-MS/MS for the LF and TMT experiments."
    ],
    "Comment[AcquisitionMethod]": [
      "DDA"
    ],
    "Comment[CollisionEnergy]": [
      "the normalized collision energy value was set to 30."
    ],
    "Comment[Separation]": [
      "bRPLC separation"
    ],
    "Comment[GradientTime]": [
      "90-minute gradient"
    ],
    "Comment[FlowRateChromatogram]": [
      "The flow rate on analytical column was 300 nl/min."
    ],
    "Comment[FractionIdentifier]": [
      "bRPLC12"
    ]
  },
  "20150820_Haura-Pilot-TMT2-bRPLC05-1.raw": {
    "Source Name": [
      "20150820_Haura-Pilot-TMT2-bRPLC05-1"
    ],
    "Assay Name": [
      "20150820_Haura-Pilot-TMT2-bRPLC05-1.raw"
    ],
    "Raw Data File": [
      "20150820_Haura-Pilot-TMT2-bRPLC05-1.raw"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin digestion was carried out overnight at 37 \u00b0C"
    ],
    "Characteristics[ReductionReagent]": [
      "reduced with 4.5 mM DTT at 60 \u00b0C for 20 minutes"
    ],
    "Characteristics[AlkylationReagent]": [
      "alkylation with 11 mM iodoacetamide at room temperature for 15 minutes in the dark"
    ],
    "Characteristics[Label]": [
      "TMT 6-plex"
    ],
    "Characteristics[MaterialType]": [
      "Tissue samples were homogenized with a BioPulverizer (Biospec) and resuspended in lysis buffer containing 20 mM HEPES, pH 8.0, 9 M urea, 1 mM sodium orthovanadate, 2.5 mM sodium pyrophosphate, and 1 mM \u03b2-glycerophosphate."
    ],
    "Characteristics[NumberOfSamples]": [
      "4 frozen lung squamous cell carcinomas and 4 adjacent tissues"
    ],
    "Characteristics[Organism]": [
      "human entries in UniProt (downloaded 05/25/2015)"
    ],
    "Characteristics[SpikedCompound]": [
      "Twenty-five femtomoles of PRTC was spiked in each LC-MS/MS analysis to monitor instrument performance (Figure S1)."
    ],
    "Comment[Instrument]": [
      "QExactive Plus, Thermo, San Jose, CA"
    ],
    "Comment[FractionationMethod]": [
      "basic pH reversed phase HPLC"
    ],
    "Comment[NumberOfFractions]": [
      "Twelve concatenated fractions were analyzed with LC-MS/MS for the LF and TMT experiments."
    ],
    "Comment[AcquisitionMethod]": [
      "DDA"
    ],
    "Comment[CollisionEnergy]": [
      "the normalized collision energy value was set to 30."
    ],
    "Comment[Separation]": [
      "bRPLC separation"
    ],
    "Comment[GradientTime]": [
      "90-minute gradient"
    ],
    "Comment[FlowRateChromatogram]": [
      "The flow rate on analytical column was 300 nl/min."
    ],
    "Comment[FractionIdentifier]": [
      "bRPLC05"
    ]
  },
  "20150820_Haura-Pilot-TMT2-bRPLC09-2.raw": {
    "Source Name": [
      "20150820_Haura-Pilot-TMT2-bRPLC09-2"
    ],
    "Assay Name": [
      "20150820_Haura-Pilot-TMT2-bRPLC09-2.raw"
    ],
    "Raw Data File": [
      "20150820_Haura-Pilot-TMT2-bRPLC09-2.raw"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin digestion was carried out overnight at 37 \u00b0C"
    ],
    "Characteristics[ReductionReagent]": [
      "reduced with 4.5 mM DTT at 60 \u00b0C for 20 minutes"
    ],
    "Characteristics[AlkylationReagent]": [
      "alkylation with 11 mM iodoacetamide at room temperature for 15 minutes in the dark"
    ],
    "Characteristics[Label]": [
      "TMT 6-plex"
    ],
    "Characteristics[MaterialType]": [
      "Tissue samples were homogenized with a BioPulverizer (Biospec) and resuspended in lysis buffer containing 20 mM HEPES, pH 8.0, 9 M urea, 1 mM sodium orthovanadate, 2.5 mM sodium pyrophosphate, and 1 mM \u03b2-glycerophosphate."
    ],
    "Characteristics[NumberOfSamples]": [
      "4 frozen lung squamous cell carcinomas and 4 adjacent tissues"
    ],
    "Characteristics[Organism]": [
      "human entries in UniProt (downloaded 05/25/2015)"
    ],
    "Characteristics[SpikedCompound]": [
      "Twenty-five femtomoles of PRTC was spiked in each LC-MS/MS analysis to monitor instrument performance (Figure S1)."
    ],
    "Comment[Instrument]": [
      "QExactive Plus, Thermo, San Jose, CA"
    ],
    "Comment[FractionationMethod]": [
      "basic pH reversed phase HPLC"
    ],
    "Comment[NumberOfFractions]": [
      "Twelve concatenated fractions were analyzed with LC-MS/MS for the LF and TMT experiments."
    ],
    "Comment[AcquisitionMethod]": [
      "DDA"
    ],
    "Comment[CollisionEnergy]": [
      "the normalized collision energy value was set to 30."
    ],
    "Comment[Separation]": [
      "bRPLC separation"
    ],
    "Comment[GradientTime]": [
      "90-minute gradient"
    ],
    "Comment[FlowRateChromatogram]": [
      "The flow rate on analytical column was 300 nl/min."
    ],
    "Comment[FractionIdentifier]": [
      "bRPLC09"
    ]
  },
  "20150820_Haura-Pilot-TMT1-bRPLC01-2.raw": {
    "Source Name": [
      "20150820_Haura-Pilot-TMT1-bRPLC01-2"
    ],
    "Assay Name": [
      "20150820_Haura-Pilot-TMT1-bRPLC01-2.raw"
    ],
    "Raw Data File": [
      "20150820_Haura-Pilot-TMT1-bRPLC01-2.raw"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin digestion was carried out overnight at 37 \u00b0C"
    ],
    "Characteristics[ReductionReagent]": [
      "reduced with 4.5 mM DTT at 60 \u00b0C for 20 minutes"
    ],
    "Characteristics[AlkylationReagent]": [
      "alkylation with 11 mM iodoacetamide at room temperature for 15 minutes in the dark"
    ],
    "Characteristics[Label]": [
      "TMT 6-plex"
    ],
    "Characteristics[MaterialType]": [
      "Tissue samples were homogenized with a BioPulverizer (Biospec) and resuspended in lysis buffer containing 20 mM HEPES, pH 8.0, 9 M urea, 1 mM sodium orthovanadate, 2.5 mM sodium pyrophosphate, and 1 mM \u03b2-glycerophosphate."
    ],
    "Characteristics[NumberOfSamples]": [
      "4 frozen lung squamous cell carcinomas and 4 adjacent tissues"
    ],
    "Characteristics[Organism]": [
      "human entries in UniProt (downloaded 05/25/2015)"
    ],
    "Characteristics[SpikedCompound]": [
      "Twenty-five femtomoles of PRTC was spiked in each LC-MS/MS analysis to monitor instrument performance (Figure S1)."
    ],
    "Comment[Instrument]": [
      "QExactive Plus, Thermo, San Jose, CA"
    ],
    "Comment[FractionationMethod]": [
      "basic pH reversed phase HPLC"
    ],
    "Comment[NumberOfFractions]": [
      "Twelve concatenated fractions were analyzed with LC-MS/MS for the LF and TMT experiments."
    ],
    "Comment[AcquisitionMethod]": [
      "DDA"
    ],
    "Comment[CollisionEnergy]": [
      "the normalized collision energy value was set to 30."
    ],
    "Comment[Separation]": [
      "bRPLC separation"
    ],
    "Comment[GradientTime]": [
      "90-minute gradient"
    ],
    "Comment[FlowRateChromatogram]": [
      "The flow rate on analytical column was 300 nl/min."
    ],
    "Comment[FractionIdentifier]": [
      "bRPLC01"
    ]
  },
  "20150820_Haura-Pilot-TMT2-bRPLC02-2.raw": {
    "Source Name": [
      "20150820_Haura-Pilot-TMT2-bRPLC02-2"
    ],
    "Assay Name": [
      "20150820_Haura-Pilot-TMT2-bRPLC02-2.raw"
    ],
    "Raw Data File": [
      "20150820_Haura-Pilot-TMT2-bRPLC02-2.raw"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin digestion was carried out overnight at 37 \u00b0C"
    ],
    "Characteristics[ReductionReagent]": [
      "reduced with 4.5 mM DTT at 60 \u00b0C for 20 minutes"
    ],
    "Characteristics[AlkylationReagent]": [
      "alkylation with 11 mM iodoacetamide at room temperature for 15 minutes in the dark"
    ],
    "Characteristics[Label]": [
      "TMT 6-plex"
    ],
    "Characteristics[MaterialType]": [
      "Tissue samples were homogenized with a BioPulverizer (Biospec) and resuspended in lysis buffer containing 20 mM HEPES, pH 8.0, 9 M urea, 1 mM sodium orthovanadate, 2.5 mM sodium pyrophosphate, and 1 mM \u03b2-glycerophosphate."
    ],
    "Characteristics[NumberOfSamples]": [
      "4 frozen lung squamous cell carcinomas and 4 adjacent tissues"
    ],
    "Characteristics[Organism]": [
      "human entries in UniProt (downloaded 05/25/2015)"
    ],
    "Characteristics[SpikedCompound]": [
      "Twenty-five femtomoles of PRTC was spiked in each LC-MS/MS analysis to monitor instrument performance (Figure S1)."
    ],
    "Comment[Instrument]": [
      "QExactive Plus, Thermo, San Jose, CA"
    ],
    "Comment[FractionationMethod]": [
      "basic pH reversed phase HPLC"
    ],
    "Comment[NumberOfFractions]": [
      "Twelve concatenated fractions were analyzed with LC-MS/MS for the LF and TMT experiments."
    ],
    "Comment[AcquisitionMethod]": [
      "DDA"
    ],
    "Comment[CollisionEnergy]": [
      "the normalized collision energy value was set to 30."
    ],
    "Comment[Separation]": [
      "bRPLC separation"
    ],
    "Comment[GradientTime]": [
      "90-minute gradient"
    ],
    "Comment[FlowRateChromatogram]": [
      "The flow rate on analytical column was 300 nl/min."
    ],
    "Comment[FractionIdentifier]": [
      "bRPLC02"
    ]
  },
  "20150820_Haura-Pilot-TMT2-bRPLC11-1.raw": {
    "Source Name": [
      "20150820_Haura-Pilot-TMT2-bRPLC11-1"
    ],
    "Assay Name": [
      "20150820_Haura-Pilot-TMT2-bRPLC11-1.raw"
    ],
    "Raw Data File": [
      "20150820_Haura-Pilot-TMT2-bRPLC11-1.raw"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin digestion was carried out overnight at 37 \u00b0C"
    ],
    "Characteristics[ReductionReagent]": [
      "reduced with 4.5 mM DTT at 60 \u00b0C for 20 minutes"
    ],
    "Characteristics[AlkylationReagent]": [
      "alkylation with 11 mM iodoacetamide at room temperature for 15 minutes in the dark"
    ],
    "Characteristics[Label]": [
      "TMT 6-plex"
    ],
    "Characteristics[MaterialType]": [
      "Tissue samples were homogenized with a BioPulverizer (Biospec) and resuspended in lysis buffer containing 20 mM HEPES, pH 8.0, 9 M urea, 1 mM sodium orthovanadate, 2.5 mM sodium pyrophosphate, and 1 mM \u03b2-glycerophosphate."
    ],
    "Characteristics[NumberOfSamples]": [
      "4 frozen lung squamous cell carcinomas and 4 adjacent tissues"
    ],
    "Characteristics[Organism]": [
      "human entries in UniProt (downloaded 05/25/2015)"
    ],
    "Characteristics[SpikedCompound]": [
      "Twenty-five femtomoles of PRTC was spiked in each LC-MS/MS analysis to monitor instrument performance (Figure S1)."
    ],
    "Comment[Instrument]": [
      "QExactive Plus, Thermo, San Jose, CA"
    ],
    "Comment[FractionationMethod]": [
      "basic pH reversed phase HPLC"
    ],
    "Comment[NumberOfFractions]": [
      "Twelve concatenated fractions were analyzed with LC-MS/MS for the LF and TMT experiments."
    ],
    "Comment[AcquisitionMethod]": [
      "DDA"
    ],
    "Comment[CollisionEnergy]": [
      "the normalized collision energy value was set to 30."
    ],
    "Comment[Separation]": [
      "bRPLC separation"
    ],
    "Comment[GradientTime]": [
      "90-minute gradient"
    ],
    "Comment[FlowRateChromatogram]": [
      "The flow rate on analytical column was 300 nl/min."
    ],
    "Comment[FractionIdentifier]": [
      "bRPLC11"
    ]
  },
  "20150820_Haura-Pilot-TMT1-bRPLC07-1.raw": {
    "Source Name": [
      "20150820_Haura-Pilot-TMT1-bRPLC07-1"
    ],
    "Assay Name": [
      "20150820_Haura-Pilot-TMT1-bRPLC07-1.raw"
    ],
    "Raw Data File": [
      "20150820_Haura-Pilot-TMT1-bRPLC07-1.raw"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin digestion was carried out overnight at 37 \u00b0C"
    ],
    "Characteristics[ReductionReagent]": [
      "reduced with 4.5 mM DTT at 60 \u00b0C for 20 minutes"
    ],
    "Characteristics[AlkylationReagent]": [
      "alkylation with 11 mM iodoacetamide at room temperature for 15 minutes in the dark"
    ],
    "Characteristics[Label]": [
      "TMT 6-plex"
    ],
    "Characteristics[MaterialType]": [
      "Tissue samples were homogenized with a BioPulverizer (Biospec) and resuspended in lysis buffer containing 20 mM HEPES, pH 8.0, 9 M urea, 1 mM sodium orthovanadate, 2.5 mM sodium pyrophosphate, and 1 mM \u03b2-glycerophosphate."
    ],
    "Characteristics[NumberOfSamples]": [
      "4 frozen lung squamous cell carcinomas and 4 adjacent tissues"
    ],
    "Characteristics[Organism]": [
      "human entries in UniProt (downloaded 05/25/2015)"
    ],
    "Characteristics[SpikedCompound]": [
      "Twenty-five femtomoles of PRTC was spiked in each LC-MS/MS analysis to monitor instrument performance (Figure S1)."
    ],
    "Comment[Instrument]": [
      "QExactive Plus, Thermo, San Jose, CA"
    ],
    "Comment[FractionationMethod]": [
      "basic pH reversed phase HPLC"
    ],
    "Comment[NumberOfFractions]": [
      "Twelve concatenated fractions were analyzed with LC-MS/MS for the LF and TMT experiments."
    ],
    "Comment[AcquisitionMethod]": [
      "DDA"
    ],
    "Comment[CollisionEnergy]": [
      "the normalized collision energy value was set to 30."
    ],
    "Comment[Separation]": [
      "bRPLC separation"
    ],
    "Comment[GradientTime]": [
      "90-minute gradient"
    ],
    "Comment[FlowRateChromatogram]": [
      "The flow rate on analytical column was 300 nl/min."
    ],
    "Comment[FractionIdentifier]": [
      "bRPLC07"
    ]
  },
  "20150820_Haura-Pilot-TMT1-bRPLC06-1.raw": {
    "Source Name": [
      "20150820_Haura-Pilot-TMT1-bRPLC06-1"
    ],
    "Assay Name": [
      "20150820_Haura-Pilot-TMT1-bRPLC06-1.raw"
    ],
    "Raw Data File": [
      "20150820_Haura-Pilot-TMT1-bRPLC06-1.raw"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin digestion was carried out overnight at 37 \u00b0C"
    ],
    "Characteristics[ReductionReagent]": [
      "reduced with 4.5 mM DTT at 60 \u00b0C for 20 minutes"
    ],
    "Characteristics[AlkylationReagent]": [
      "alkylation with 11 mM iodoacetamide at room temperature for 15 minutes in the dark"
    ],
    "Characteristics[Label]": [
      "TMT 6-plex"
    ],
    "Characteristics[MaterialType]": [
      "Tissue samples were homogenized with a BioPulverizer (Biospec) and resuspended in lysis buffer containing 20 mM HEPES, pH 8.0, 9 M urea, 1 mM sodium orthovanadate, 2.5 mM sodium pyrophosphate, and 1 mM \u03b2-glycerophosphate."
    ],
    "Characteristics[NumberOfSamples]": [
      "4 frozen lung squamous cell carcinomas and 4 adjacent tissues"
    ],
    "Characteristics[Organism]": [
      "human entries in UniProt (downloaded 05/25/2015)"
    ],
    "Characteristics[SpikedCompound]": [
      "Twenty-five femtomoles of PRTC was spiked in each LC-MS/MS analysis to monitor instrument performance (Figure S1)."
    ],
    "Comment[Instrument]": [
      "QExactive Plus, Thermo, San Jose, CA"
    ],
    "Comment[FractionationMethod]": [
      "basic pH reversed phase HPLC"
    ],
    "Comment[NumberOfFractions]": [
      "Twelve concatenated fractions were analyzed with LC-MS/MS for the LF and TMT experiments."
    ],
    "Comment[AcquisitionMethod]": [
      "DDA"
    ],
    "Comment[CollisionEnergy]": [
      "the normalized collision energy value was set to 30."
    ],
    "Comment[Separation]": [
      "bRPLC separation"
    ],
    "Comment[GradientTime]": [
      "90-minute gradient"
    ],
    "Comment[FlowRateChromatogram]": [
      "The flow rate on analytical column was 300 nl/min."
    ],
    "Comment[FractionIdentifier]": [
      "bRPLC06"
    ]
  },
  "20150820_Haura-Pilot-TMT2-bRPLC08-2.raw": {
    "Source Name": [
      "20150820_Haura-Pilot-TMT2-bRPLC08-2"
    ],
    "Assay Name": [
      "20150820_Haura-Pilot-TMT2-bRPLC08-2.raw"
    ],
    "Raw Data File": [
      "20150820_Haura-Pilot-TMT2-bRPLC08-2.raw"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin digestion was carried out overnight at 37 \u00b0C"
    ],
    "Characteristics[ReductionReagent]": [
      "reduced with 4.5 mM DTT at 60 \u00b0C for 20 minutes"
    ],
    "Characteristics[AlkylationReagent]": [
      "alkylation with 11 mM iodoacetamide at room temperature for 15 minutes in the dark"
    ],
    "Characteristics[Label]": [
      "TMT 6-plex"
    ],
    "Characteristics[MaterialType]": [
      "Tissue samples were homogenized with a BioPulverizer (Biospec) and resuspended in lysis buffer containing 20 mM HEPES, pH 8.0, 9 M urea, 1 mM sodium orthovanadate, 2.5 mM sodium pyrophosphate, and 1 mM \u03b2-glycerophosphate."
    ],
    "Characteristics[NumberOfSamples]": [
      "4 frozen lung squamous cell carcinomas and 4 adjacent tissues"
    ],
    "Characteristics[Organism]": [
      "human entries in UniProt (downloaded 05/25/2015)"
    ],
    "Characteristics[SpikedCompound]": [
      "Twenty-five femtomoles of PRTC was spiked in each LC-MS/MS analysis to monitor instrument performance (Figure S1)."
    ],
    "Comment[Instrument]": [
      "QExactive Plus, Thermo, San Jose, CA"
    ],
    "Comment[FractionationMethod]": [
      "basic pH reversed phase HPLC"
    ],
    "Comment[NumberOfFractions]": [
      "Twelve concatenated fractions were analyzed with LC-MS/MS for the LF and TMT experiments."
    ],
    "Comment[AcquisitionMethod]": [
      "DDA"
    ],
    "Comment[CollisionEnergy]": [
      "the normalized collision energy value was set to 30."
    ],
    "Comment[Separation]": [
      "bRPLC separation"
    ],
    "Comment[GradientTime]": [
      "90-minute gradient"
    ],
    "Comment[FlowRateChromatogram]": [
      "The flow rate on analytical column was 300 nl/min."
    ],
    "Comment[FractionIdentifier]": [
      "bRPLC08"
    ]
  },
  "20150820_Haura-Pilot-TMT1-bRPLC04-1.raw": {
    "Source Name": [
      "20150820_Haura-Pilot-TMT1-bRPLC04-1"
    ],
    "Assay Name": [
      "20150820_Haura-Pilot-TMT1-bRPLC04-1.raw"
    ],
    "Raw Data File": [
      "20150820_Haura-Pilot-TMT1-bRPLC04-1.raw"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin digestion was carried out overnight at 37 \u00b0C"
    ],
    "Characteristics[ReductionReagent]": [
      "reduced with 4.5 mM DTT at 60 \u00b0C for 20 minutes"
    ],
    "Characteristics[AlkylationReagent]": [
      "alkylation with 11 mM iodoacetamide at room temperature for 15 minutes in the dark"
    ],
    "Characteristics[Label]": [
      "TMT 6-plex"
    ],
    "Characteristics[MaterialType]": [
      "Tissue samples were homogenized with a BioPulverizer (Biospec) and resuspended in lysis buffer containing 20 mM HEPES, pH 8.0, 9 M urea, 1 mM sodium orthovanadate, 2.5 mM sodium pyrophosphate, and 1 mM \u03b2-glycerophosphate."
    ],
    "Characteristics[NumberOfSamples]": [
      "4 frozen lung squamous cell carcinomas and 4 adjacent tissues"
    ],
    "Characteristics[Organism]": [
      "human entries in UniProt (downloaded 05/25/2015)"
    ],
    "Characteristics[SpikedCompound]": [
      "Twenty-five femtomoles of PRTC was spiked in each LC-MS/MS analysis to monitor instrument performance (Figure S1)."
    ],
    "Comment[Instrument]": [
      "QExactive Plus, Thermo, San Jose, CA"
    ],
    "Comment[FractionationMethod]": [
      "basic pH reversed phase HPLC"
    ],
    "Comment[NumberOfFractions]": [
      "Twelve concatenated fractions were analyzed with LC-MS/MS for the LF and TMT experiments."
    ],
    "Comment[AcquisitionMethod]": [
      "DDA"
    ],
    "Comment[CollisionEnergy]": [
      "the normalized collision energy value was set to 30."
    ],
    "Comment[Separation]": [
      "bRPLC separation"
    ],
    "Comment[GradientTime]": [
      "90-minute gradient"
    ],
    "Comment[FlowRateChromatogram]": [
      "The flow rate on analytical column was 300 nl/min."
    ],
    "Comment[FractionIdentifier]": [
      "bRPLC04"
    ]
  },
  "20150820_Haura-Pilot-TMT1-bRPLC04-2.raw": {
    "Source Name": [
      "20150820_Haura-Pilot-TMT1-bRPLC04-2"
    ],
    "Assay Name": [
      "20150820_Haura-Pilot-TMT1-bRPLC04-2.raw"
    ],
    "Raw Data File": [
      "20150820_Haura-Pilot-TMT1-bRPLC04-2.raw"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin digestion was carried out overnight at 37 \u00b0C"
    ],
    "Characteristics[ReductionReagent]": [
      "reduced with 4.5 mM DTT at 60 \u00b0C for 20 minutes"
    ],
    "Characteristics[AlkylationReagent]": [
      "alkylation with 11 mM iodoacetamide at room temperature for 15 minutes in the dark"
    ],
    "Characteristics[Label]": [
      "TMT 6-plex"
    ],
    "Characteristics[MaterialType]": [
      "Tissue samples were homogenized with a BioPulverizer (Biospec) and resuspended in lysis buffer containing 20 mM HEPES, pH 8.0, 9 M urea, 1 mM sodium orthovanadate, 2.5 mM sodium pyrophosphate, and 1 mM \u03b2-glycerophosphate."
    ],
    "Characteristics[NumberOfSamples]": [
      "4 frozen lung squamous cell carcinomas and 4 adjacent tissues"
    ],
    "Characteristics[Organism]": [
      "human entries in UniProt (downloaded 05/25/2015)"
    ],
    "Characteristics[SpikedCompound]": [
      "Twenty-five femtomoles of PRTC was spiked in each LC-MS/MS analysis to monitor instrument performance (Figure S1)."
    ],
    "Comment[Instrument]": [
      "QExactive Plus, Thermo, San Jose, CA"
    ],
    "Comment[FractionationMethod]": [
      "basic pH reversed phase HPLC"
    ],
    "Comment[NumberOfFractions]": [
      "Twelve concatenated fractions were analyzed with LC-MS/MS for the LF and TMT experiments."
    ],
    "Comment[AcquisitionMethod]": [
      "DDA"
    ],
    "Comment[CollisionEnergy]": [
      "the normalized collision energy value was set to 30."
    ],
    "Comment[Separation]": [
      "bRPLC separation"
    ],
    "Comment[GradientTime]": [
      "90-minute gradient"
    ],
    "Comment[FlowRateChromatogram]": [
      "The flow rate on analytical column was 300 nl/min."
    ],
    "Comment[FractionIdentifier]": [
      "bRPLC04"
    ]
  },
  "20150820_Haura-Pilot-TMT1-bRPLC11-2.raw": {
    "Source Name": [
      "20150820_Haura-Pilot-TMT1-bRPLC11-2"
    ],
    "Assay Name": [
      "20150820_Haura-Pilot-TMT1-bRPLC11-2.raw"
    ],
    "Raw Data File": [
      "20150820_Haura-Pilot-TMT1-bRPLC11-2.raw"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin digestion was carried out overnight at 37 \u00b0C"
    ],
    "Characteristics[ReductionReagent]": [
      "reduced with 4.5 mM DTT at 60 \u00b0C for 20 minutes"
    ],
    "Characteristics[AlkylationReagent]": [
      "alkylation with 11 mM iodoacetamide at room temperature for 15 minutes in the dark"
    ],
    "Characteristics[Label]": [
      "TMT 6-plex"
    ],
    "Characteristics[MaterialType]": [
      "Tissue samples were homogenized with a BioPulverizer (Biospec) and resuspended in lysis buffer containing 20 mM HEPES, pH 8.0, 9 M urea, 1 mM sodium orthovanadate, 2.5 mM sodium pyrophosphate, and 1 mM \u03b2-glycerophosphate."
    ],
    "Characteristics[NumberOfSamples]": [
      "4 frozen lung squamous cell carcinomas and 4 adjacent tissues"
    ],
    "Characteristics[Organism]": [
      "human entries in UniProt (downloaded 05/25/2015)"
    ],
    "Characteristics[SpikedCompound]": [
      "Twenty-five femtomoles of PRTC was spiked in each LC-MS/MS analysis to monitor instrument performance (Figure S1)."
    ],
    "Comment[Instrument]": [
      "QExactive Plus, Thermo, San Jose, CA"
    ],
    "Comment[FractionationMethod]": [
      "basic pH reversed phase HPLC"
    ],
    "Comment[NumberOfFractions]": [
      "Twelve concatenated fractions were analyzed with LC-MS/MS for the LF and TMT experiments."
    ],
    "Comment[AcquisitionMethod]": [
      "DDA"
    ],
    "Comment[CollisionEnergy]": [
      "the normalized collision energy value was set to 30."
    ],
    "Comment[Separation]": [
      "bRPLC separation"
    ],
    "Comment[GradientTime]": [
      "90-minute gradient"
    ],
    "Comment[FlowRateChromatogram]": [
      "The flow rate on analytical column was 300 nl/min."
    ],
    "Comment[FractionIdentifier]": [
      "bRPLC11"
    ]
  },
  "20150820_Haura-Pilot-TMT1-bRPLC10-1.raw": {
    "Source Name": [
      "20150820_Haura-Pilot-TMT1-bRPLC10-1"
    ],
    "Assay Name": [
      "20150820_Haura-Pilot-TMT1-bRPLC10-1.raw"
    ],
    "Raw Data File": [
      "20150820_Haura-Pilot-TMT1-bRPLC10-1.raw"
    ],
    "Characteristics[CleavageAgent]": [
      "trypsin digestion was carried out overnight at 37 \u00b0C"
    ],
    "Characteristics[ReductionReagent]": [
      "reduced with 4.5 mM DTT at 60 \u00b0C for 20 minutes"
    ],
    "Characteristics[AlkylationReagent]": [
      "alkylation with 11 mM iodoacetamide at room temperature for 15 minutes in the dark"
    ],
    "Characteristics[Label]": [
      "TMT 6-plex"
    ],
    "Characteristics[MaterialType]": [
      "Tissue samples were homogenized with a BioPulverizer (Biospec) and resuspended in lysis buffer containing 20 mM HEPES, pH 8.0, 9 M urea, 1 mM sodium orthovanadate, 2.5 mM sodium pyrophosphate, and 1 mM \u03b2-glycerophosphate."
    ],
    "Characteristics[NumberOfSamples]": [
      "4 frozen lung squamous cell carcinomas and 4 adjacent tissues"
    ],
    "Characteristics[Organism]": [
      "human entries in UniProt (downloaded 05/25/2015)"
    ],
    "Characteristics[SpikedCompound]": [
      "Twenty-five femtomoles of PRTC was spiked in each LC-MS/MS analysis to monitor instrument performance (Figure S1)."
    ],
    "Comment[Instrument]": [
      "QExactive Plus, Thermo, San Jose, CA"
    ],
    "Comment[FractionationMethod]": [
      "basic pH reversed phase HPLC"
    ],
    "Comment[NumberOfFractions]": [
      "Twelve concatenated fractions were analyzed with LC-MS/MS for the LF and TMT experiments."
    ],
    "Comment[AcquisitionMethod]": [
      "DDA"
    ],
    "Comment[CollisionEnergy]": [
      "the normalized collision energy value was set to 30."
    ],
    "Comment[Separation]": [
      "bRPLC separation"
    ],
    "Comment[GradientTime]": [
      "90-minute gradient"
    ],
    "Comment[FlowRateChromatogram]": [
      "The flow rate on analytical column was 300 nl/min."
    ],
    "Comment[FractionIdentifier]": [
      "bRPLC10"
    ]
  }
}